<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation - Kirkman, MA - 2022 | Cochrane Library</title> <meta content="Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation - Kirkman, MA - 2022 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011335.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation - Kirkman, MA - 2022 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011335.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011335.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation" name="citation_title"/> <meta content="Matthew A Kirkman" name="citation_author"/> <meta content="Queen's Medical Centre, Nottingham University Hospitals NHS Trust" name="citation_author_institution"/> <meta content="matthew.kirkman@gmail.com" name="citation_author_email"/> <meta content="Julia Day" name="citation_author"/> <meta content="Strathbrock Partnership Centre" name="citation_author_institution"/> <meta content="Karin Gehring" name="citation_author"/> <meta content="Karolis Zienius" name="citation_author"/> <meta content="Western General Hospital" name="citation_author_institution"/> <meta content="David Grosshans" name="citation_author"/> <meta content="MD Anderson Cancer Center" name="citation_author_institution"/> <meta content="Martin Taphoorn" name="citation_author"/> <meta content="Haaglanden Medical Center" name="citation_author_institution"/> <meta content="Jing Li" name="citation_author"/> <meta content="MD Anderson Cancer Center" name="citation_author_institution"/> <meta content="Paul D Brown" name="citation_author"/> <meta content="Mayo Clinic" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD011335.pub3" name="citation_doi"/> <meta content="2022" name="citation_date"/> <meta content="2022/11/25" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011335.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011335.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011335.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Brain Neoplasms; Cognition; *Cognitive Dysfunction [etiology, prevention &amp; control]; Cranial Irradiation [adverse effects]; *Dementia; Donepezil; Fatigue [etiology, prevention &amp; control]; Memantine; *Methylphenidate [therapeutic use]; Modafinil [therapeutic use]; Quality of Life" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011335.pub3&amp;doi=10.1002/14651858.CD011335.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="bzu3XIhG";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011335\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011335\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011335\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011335\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANT","ko","pt","ms","ja","id","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011335.pub3",title:"Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation",firstPublishedDate:"Nov 25, 2022 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=bzu3XIhG&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011335.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011335.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011335.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011335.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011335.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011335.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;id&quot;,&quot;title&quot;:&quot;Saripati tinjauan sistematik&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011335.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011335.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011335.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011335.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2608 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011335.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/full#CD011335-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/full#CD011335-sec-0103"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/full#CD011335-sec-0008"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/full#CD011335-sec-0020"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/full#CD011335-sec-0021"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/full#CD011335-sec-0051"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/full#CD011335-sec-0095"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/appendices#CD011335-sec-0108"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/supinfo/CD011335StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/supinfo/CD011335StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2022 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/information#CD011335-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Matthew A Kirkman</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/information#CD011335-cr-0005">Julia Day</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/information#CD011335-cr-0006">Karin Gehring</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/information#CD011335-cr-0007">Karolis Zienius</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/information#CD011335-cr-0008">David Grosshans</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/information#CD011335-cr-0009">Martin Taphoorn</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/information#CD011335-cr-0010">Jing Li</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011335.pub3/information#CD011335-cr-0011">Paul D Brown</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/information/en#CD011335-sec-0125">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 25 November 2022 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011335.pub3">https://doi.org/10.1002/14651858.CD011335.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011335-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011335-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011335-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011335-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011335-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD011335-abs-0005">한국어</a> </li> <li class="section-language"> <a class="" href="full/pt#CD011335-abs-0007">Português</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011335-abs-0001" lang="en"> <section id="CD011335-sec-0001"> <h3 class="title" id="CD011335-sec-0001">Background</h3> <p>Cognitive deficits are common in people who have received cranial irradiation and have a serious impact on daily functioning and quality of life. The benefit of pharmacological and non‐pharmacological treatment of cognitive deficits in this population is unclear. This is an updated version of the original Cochrane Review published in Issue 12, 2014. </p> </section> <section id="CD011335-sec-0002"> <h3 class="title" id="CD011335-sec-0002">Objectives</h3> <p>To assess the effectiveness of interventions for preventing or ameliorating cognitive deficits in adults treated with cranial irradiation. </p> </section> <section id="CD011335-sec-0003"> <h3 class="title" id="CD011335-sec-0003">Search methods</h3> <p>For this review update we searched the Cochrane Register of Controlled Trials (CENTRAL), MEDLINE via Ovid, Embase via Ovid, and PsycInfo via Ovid to 12 September 2022. </p> </section> <section id="CD011335-sec-0004"> <h3 class="title" id="CD011335-sec-0004">Selection criteria</h3> <p>We included randomised controlled (RCTs) trials that evaluated pharmacological or non‐pharmacological interventions in cranial irradiated adults, with objective cognitive functioning as a primary or secondary outcome measure. </p> </section> <section id="CD011335-sec-0005"> <h3 class="title" id="CD011335-sec-0005">Data collection and analysis</h3> <p>Two review authors (MK, JD) independently extracted data from selected studies and carried out a risk of bias assessment. Cognitive function, fatigue and mood outcomes were reported. No data were pooled. </p> </section> <section id="CD011335-sec-0006"> <h3 class="title" id="CD011335-sec-0006">Main results</h3> <p>Eight studies met the inclusion criteria and were included in this updated review. Six were from the original version of the review, and two more were added when the search was updated. Nineteen further studies were assessed as part of this update but did not fulfil the inclusion criteria. </p> <p>Of the eight included studies, four studies investigated “prevention” of cognitive problems (during radiotherapy and follow‐up) and four studies investigated “amelioration” (interventions to treat cognitive impairment as a late complication of radiotherapy). There were five pharmacological studies (two studies on prevention and three in amelioration) and three non‐pharmacological studies (two on prevention and one in amelioration). Due to differences between studies in the interventions being evaluated, a meta‐analysis was not possible.  </p> <p><b>Studies in early radiotherapy treatment phase (five studies)</b> </p> <p>Pharmacological studies in the “early radiotherapy treatment phase” were designed to prevent or ameliorate cognitive deficits and included drugs used in dementia (memantine) and fatigue (d‐threo‐methylphenidate hydrochloride). Non‐pharmacological studies in the “early radiotherapy treatment phase” included a ketogenic diet and a two‐week cognitive rehabilitation and problem‐solving programme.  </p> <p>In the memantine study, the primary cognitive outcome of memory at six months did not reach significance, but there was significant improvement in overall cognitive function compared to placebo, with similar adverse events across groups. The d‐threo‐methylphenidate hydrochloride study found no statistically significant difference between arms, with few adverse events. The study of a calorie‐restricted ketogenic diet found no effect, although a lower than expected calorie intake in the control group complicates interpretation of the results.  The study investigating the utility of a rehabilitation program did not carry out a statistical comparison of cognitive performance between groups.  </p> <p><b>Studies in delayed radiation or late effect phase (four studies)</b> </p> <p>The “amelioration” pharmacological studies to treat cognitive complications of radiotherapy included drugs used in dementia (donepezil) or psychostimulants (methylphenidate and modafinil). Non‐pharmacological measures included cognitive rehabilitation and problem solving (Goal Management Training). These studies included patients with cognitive problems at entry who had “stable” brain cancer.  </p> <p>The donepezil study did not find an improvement in the primary cognitive outcome of overall cognitive performance, but did find improvement in an individual test of memory, compared to placebo; adverse events were not reported. A study comparing methylphenidate with modafinil found improvements in cognitive function in both the methylphenidate and modafinil arms; few adverse events were reported. Another  study comparing two different doses of modafinil combined treatment arms and found improvements across all cognitive tests, however, a number of adverse events were reported. Both studies were limited by a small sample size. The Goal Management Training study suggested a benefit of the intervention, a behavioural intervention that combined mindfulness and strategy training, on executive function and processing speed.  </p> <p>There were a number of limitations across studies and few were without high risks of bias. </p> </section> <section id="CD011335-sec-0007"> <h3 class="title" id="CD011335-sec-0007">Authors' conclusions</h3> <p>In this update, limited additional evidence was found for the treatment or amelioration of cognitive deficits in adults treated with cranial irradiation. As concluded in the original review, there is supportive evidence that memantine may help prevent cognitive deficits for adults with brain metastases receiving cranial irradiation. There is supportive evidence that donepezil, methylphenidate and modafinil may have a role in treating cognitive deficits in adults with brain tumours who have been treated with cranial irradiation; patient withdrawal affected the statistical power of these studies. Further research that tries to minimise the withdrawal of consent, and subsequently reduce the requirement for imputation procedures, may offer a higher certainty of evidence. </p> <p>There is evidence from only a single small study to support non‐pharmacological interventions in the amelioration of cognitive deficits. Further research is required. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011335-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011335-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011335-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011335-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011335-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011335-abs-0015">Français</a> </li> <li class="section-language"> <a class="" href="full/id#CD011335-abs-0011">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="full/ja#CD011335-abs-0010">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD011335-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011335-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD011335-abs-0008">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD011335-abs-0004">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011335-abs-0002" lang="en"> <h3>Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation </h3> <p><b>Background</b> </p> <p>Problems with mental/cognitive abilities/skills (cognitive side effects) are common in people who have received radiation to the brain for a primary or secondary (metastatic) brain tumour, or for preventing a tumour from spreading to the brain from elsewhere in the body. This toxic side effect of brain radiation may be acute (during treatment) or early after treatment (one to six months) and may be reversible. However, later toxicities may occur many months or years later, and when they do occur they are generally irreversible and often slowly progressive. Late cognitive deficits, such as memory loss, problems planning tasks or behavioural changes, can have a serious impact on quality of life and the ability to carry out activities normally. Interventions to help prevent or treat these late radiation toxicities may improve a patient's well‐being. Here, we review all studies on pharmacological (medical drug) and non‐pharmacological (psychological) interventions that aimed to prevent or treat cognitive side effects associated with radiotherapy to the brain.  </p> <p><b>Study Characteristics</b> </p> <p>In the original review published in August 2014, we searched four literature databases, which are used to identify articles from peer‐reviewed journals and other types of periodicals. Six randomised controlled trials, in which people were randomly assigned to the intervention or a comparison group (control group), were eligible for inclusion. Each trial assessed different interventions, so results were not combined. The largest trial investigated the medical drug memantine in 508 people with a metastatic brain tumour. Another trial investigated donepezil in 198 patients with a primary or secondary brain tumour. The other trials were smaller and investigated modafinil and methylphenidate. We found one psychological intervention for preventing cognitive deficits during brain radiation.  </p> <p>In this update, we searched the same databases as in the original review. Two new studies were included in the review. One of these was a non‐pharmacological prevention study investigating the effect of a calorie‐restricted ketogenic diet and intermittent fasting. The other identified study was a non‐pharmacological amelioration study evaluating Goal Management Training, a behavioural intervention that combined mindfulness and strategy training. An additional paper included in the review was the full‐text article of a conference proceeding included in the original review, which investigated donepezil compared with placebo.  </p> <p><b>Key findings</b> </p> <p>Findings into the efficacy of memantine offer preliminary supportive evidence for preventing cognitive deficits in patients with a secondary brain tumour receiving brain irradiation. Findings into the efficacy of donepezil offer some initial support for its use in the amelioration of cognitive deficits in patients with a primary or secondary tumour previously treated with radiation. Further research into both drugs is important to confirm their effectiveness as well as any potential side effects. The remaining studies did not have a sufficient number of participants to provide reliable results. Side effects (adverse events) were not reported in all studies, but in studies where they were, they were most often infrequent and not severe. Recruitment and retention of trial participants for most of the pharmacological studies was difficult. Lastly, although limited support was found for non‐pharmacological treatments, this does not suggest these interventions are ineffective but rather that further research is needed. </p> <p><b>Certainty of the evidence</b> </p> <p>We found limitations in the certainty of the evidence across studies. Several of the pharmacological randomised controlled trials had a low risk of bias, although some were at high risk of bias due to, for example, an open‐label design or the lack of a placebo group. The non‐pharmacological interventions were at a high risk of bias as a placebo condition in these trials is difficult to employ. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011335-sec-0103" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011335-sec-0103"></div> <h3 class="title" id="CD011335-sec-0104">Implications for practice</h3> <section id="CD011335-sec-0104"> <p>One study provided supportive evidence that memantine in the early radiotherapy treatment phase may improve some of the objective neuropsychological tests of cognition. The benefit to day‐to‐day memory is uncertain. Adverse events were similar across groups. Memantine may therefore be a safe agent for people with brain metastases receiving whole brain radiotherapy; there is evidence supporting its favourable long‐term safety profile in Alzheimer's disease (<a href="./references#CD011335-bbs2-0060" title="FarlowMR , GrahamSM , AlvaG . Memantine for the treatment of Alzheimer's disease: tolerability and safety data from clinical trials. Drug Safety2008;31(7):577-85.">Farlow 2008</a>) and migraine (<a href="./references#CD011335-bbs2-0090" title="MistryVM , MorizioPL , PepinMJ , BryanWE , BrownJN . Role of memantine in the prophylactic treatment of episodic migraine: a systematic review. Headache2021;61(8):1207-13.">Mistry 2021</a>), but further long‐term evidence is required to confirm this applies to patients receiving cranial irradiation. One study provided supportive evidence that donepezil in the delayed radiation/late effect phase may improve some of the objective neuropsychological tests of cognition. The benefit to day‐to‐day memory is uncertain. Adverse events were not reported. However, it is noted that these supportive findings for memantine and donepezil were for both study's secondary outcomes (time to cognitive failure in the memantine study and memory in the donepezil study); negative findings were found for the primary outcomes (preserved cognitive function in the memantine study and a cognitive composite score in the donepezil study), although the primary endpoint nearly reached statistical significance for memantine. Caution is required in the interpretation of these secondary outcome results in the presence of non‐significant primary outcome measures.  </p> <p>Two studies offered some evidence for the role of central nervous system stimulants in preventing or improving cognitive deficits with few adverse events; these studies were limited by a small sample size, and one by practice effects. There is currently limited evidence to suggest non‐pharmacological interventions are beneficial in the prevention or amelioration of cognitive deficits in adults treated with cranial irradiation, with only one very small study suggesting a benefit of Goal Management Training, a behavioural intervention that combined mindfulness and strategy training, on executive function and processing speed. There was no effect of a nine‐day calorie‐restricted ketogenic diet with intermittent fasting during re‐irradiation on cognitive function in patients with recurrent glioblastomas. </p> </section> <h3 class="title" id="CD011335-sec-0105">Implications for research</h3> <section id="CD011335-sec-0105"> <p>In part due to the increased survival of patients with brain tumours and the effects of cognitive dysfunction on quality of life of patients and their caregivers, interventions to address and prevent cognitive dysfunction in this population have gained increasing research interest. However, much more high‐quality research is required to address this unmet need and to overcome some of the limitations of previous studies. </p> <p>There are challenges in performing research in patients with primary and metastatic brain tumours. High drop‐out rates are to be expected in studies examining prophylactic cranial irradiation and therapeutic cranial irradiation. This is due to progression of systemic cancer or primary brain tumours leading to death, disability or affecting quality of life resulting in study withdrawal. Further research is necessary to determine whether memantine is effective in other patient populations receiving cranial irradiation, including patients with primary brain tumours and patients with tumours elsewhere in the body receiving prophylactic cranial irradiation. Further research is required in other pharmacological agents, for example, the effects of methylphenidate and modafinil are still to be clarified. Sufficient attempts to recruit and maintain sufficient numbers of participants is essential. Appropriate control groups are necessary to rule out practice effects and determine the efficacy compared to standard care. It is also important to identify and report patient characteristics and use of other medications, such as steroid and anti‐epileptic drugs, which are associated with impaired cognitive function. </p> <p>Further research is needed to determine the efficacy of cognitive rehabilitation in this patient population. Other studies that have investigated cognitive rehabilitation programmes in patient groups with other types of brain tumour offer detailed descriptions of eHealth cognitive interventions that could be investigated (<a href="./references#CD011335-bbs2-0016" title="GehringK , SitskoornMM , GundyCM , SikkesSA , KleinM , PostmaTJ , et al. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. Journal of Clinical Oncology2009;27(22):3712-22. [DOI: 10.1200/JCO.2008.20.5765]">Gehring 2009</a>; <a href="./references#CD011335-bbs2-0065" title="GehringK , AaronsonNK , GundyCM , TaphoornMJ , SitskoornMM . Predictors of neuropsychological improvement following cognitive rehabilitation in patients with gliomas. Journal of International Neuropsychological Society2011;17(2):256-66.">Gehring 2011</a>; <a href="./references#CD011335-bbs2-0075" title="HasslerMR , ElandtK , PreusserM , LehrnerJ , BinderP , DieckmannK , et al. Neurocognitive training in patients with high-grade glioma: a pilot study. Journal of Neuro-Oncology2010;97(1):109-15.">Hassler 2010</a>; <a href="./references#CD011335-bbs2-0131" title="ZucchellaC , CaponeA , CodellaV , De NunzioAM , VecchioneC , SandriniG , et al. Cognitive rehabilitation for early post-surgery inpatients affected by primary brain tumor: a randomized, controlled trial. Journal of Neuro-Oncology2013;114(1):93-100.">Zucchella 2013</a>; <a href="./references#CD011335-bbs2-0034" title="van derLindenSD , RuttenGM , DirvenL , TaphoornMJB , SatoerDD , DirvenCMF , et al. eHealth cognitive rehabilitation for brain tumor patients: results of a randomized controlled trial. Journal of Neuro-oncology2021;154(3):315-26. [DOI: 10.1007/s11060-021-03828-1]">van der Linden 2021</a>). </p> <p>Exercise may also be a useful treatment for counteracting impairments associated with brain tumours, including fatigue, functional decline, cognitive impairment, and depression as well as anxiety (<a href="./references#CD011335-bbs2-0049" title="CormieP , NowakAK , ChambersSK , GalvãoDA , NewtonRU . The potential role of exercise in neuro-oncology. Frontiers of Oncology2015;5:85. [DOI: 10.3389/fonc.2015.00085]">Cormie 2015</a>; <a href="./references#CD011335-bbs2-0018" title="GehringK , StuiverMM , VisserE , KloekC , vanden BentM , HanseM , et al. A pilot randomized controlled trial of exercise to improve cognitive performance in patients with stable glioma: a proof of concept. Neuro Oncology2020;22(1):103-15. ">Gehring 2020</a>). </p> <p>Lastly, non‐randomised trials and observational studies reporting other non‐pharmacological interventions including hyperbaric oxygen therapy and dietary supplements such as vitamin E and <i>Ginkgo biloba</i> also provide results that could be explored further using appropriate control groups, blinding, and when funding is more accessible. </p> <p>Finally, the alignment of cognitive outcome assessments using the same tools would help improve the homogeneity and thus comparability of data across studies. One way to achieve this could be through greater collaboration between centres. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011335-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011335-sec-0008"></div> <section id="CD011335-sec-0009"> <h3 class="title" id="CD011335-sec-0009">Description of the condition</h3> <p>Cognition refers to the mental abilities that require the high‐level handling of information. Such abilities include learning and memory, executive function, visuo‐spatial processing, language, concentration, attention and intellectual function (<a href="./references#CD011335-bbs2-0069" title="GilroyJ . Basic Neurology. 3rd edition. New York: McGraw-Hill Health Professions Division, 2000.">Gilroy 2000</a>). Cognitive dysfunction (or deficit) in any of these areas can have a significant impact on a person's ability to function in day‐to‐day life, including work performance, language and communication, social interactions and independent living (<a href="./references#CD011335-bbs2-0024" title="MeyersCA , WeitznerMA , ValentineAD , LevinVA . Methylphenidate therapy improves cognition, mood and function of brain tumor patients. Journal of Clinical Oncology1998;16(7):2522-7. ">Meyers 1998</a>). </p> <p>Cognitive deficits are common among patients who have received cranial irradiation (<a href="./references#CD011335-bbs2-0079" title="KirkmanMA , HunnBH , ThomasMS , TolmieAK . Influences on cognitive outcomes in adult patients with gliomas: a systematic review. Frontiers in Oncology2022;12:943600.">Kirkman 2022</a>; <a href="./references#CD011335-bbs2-0082" title="LehrerEJ , JonesBM , DicksteinDR , GreenS , GermanoIM , PalmerJD , et al. The Cognitive Effects of Radiotherapy for Brain Metastases. Frontiers in Oncology2022;12:893264.">Lehrer 2022</a>; <a href="./references#CD011335-bbs2-0098" title="PerezWD , Perez-TorresCJ . Neurocognitive and radiological changes after cranial radiation therapy in humans and rodents: a systematic review. International Journal of Radiation Biology 2022 [Epub ahead of print]. [DOI: 10.1080/09553002.2022.2074167]">Perez 2022</a>) to treat primary or metastatic brain tumours, or as prevention (prophylaxis) of other cancers. Both the brain tumour itself and tumour treatment can cause cognitive deficits (<a href="./references#CD011335-bbs2-0079" title="KirkmanMA , HunnBH , ThomasMS , TolmieAK . Influences on cognitive outcomes in adult patients with gliomas: a systematic review. Frontiers in Oncology2022;12:943600.">Kirkman 2022</a>; <a href="./references#CD011335-bbs2-0116" title="TaphoornMJ , KleinM . Cognitive deficits in adult patients with brain tumours. Lancet Neurology2004;3(3):159-68.">Taphoorn 2004</a>), and patients with brain tumours who receive radiotherapy tend to have worse cognitive deficits than those who are radiotherapy naive, with identified neuroimaging correlates including cortical atrophy and white matter abnormalities (<a href="./references#CD011335-bbs2-0051" title="CorreaDD , DeAngelisLM , ShiW , ThalerHT , LinM , AbreyLE . Cognitive functions in low-grade gliomas: disease and treatment effects. Journal of Neurooncology2007;81(2):175-84. [DOI: 10.1007/s11060-006-9212-3]">Correa 2007</a>; <a href="./references#CD011335-bbs2-0099" title="PostmaTJ , KleinM , VerstappenCC , BrombergJE , SwennenM , LangendijkJA , et al. Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma. Neurology2002;59(1):121-3. [DOI: 10.1212/wnl.59.1.121]">Postma 2002</a>; <a href="./references#CD011335-bbs2-0112" title="Surma-ahoO , NiemeläM , VilkkiJ , KouriM , BranderA , SalonenO , et al. Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology2001;56(10):1285-1290. [DOI: 10.1212/wnl.56.10.1285]">Surma‐aho 2001</a>; <a href="./references#CD011335-bbs2-0111" title="SultanaN , SunC , KatsubeT , WangB . Biomarkers of brain damage induced by radiotherapy. Dose Response2020;18(3):1559325820938279.">Sultana 2020</a>). Over 80% of primary and metastatic brain tumour patients have self‐reported cognitive concerns regarding memory or concentration (<a href="./references#CD011335-bbs2-0083" title="LidstoneV , ButtersE , SeedPT , SinnottC , BeynonT , RichardsM . Symptoms and concerns amongst cancer outpatients: identifying the need for specialist palliative care. Palliative Medicine2003;17(7):588-95.">Lidstone 2003</a>; <a href="./references#CD011335-bbs2-0094" title="MukandJA , BlackintonDD , CrincoliMG , LeeJJ , SantosBB . Incidence of neurologic deficits and rehabilitation of patients with brain tumors. American Journal of Physical Medicine &amp; Rehabilitation2001;80(5):346-50.">Mukand 2001</a>). For example, in a prospective study, cognitive functioning was assessed with neuropsychological testing in patients receiving cranial irradiation for the treatment of brain metastases. Results demonstrated cognitive deficits in the domains of learning, delayed recall and recognition six to eight weeks following radiotherapy when compared to baseline scores (<a href="./references#CD011335-bbs2-0127" title="WelzelG , FleckensteinK , SchaeferJ , HermannB , Kraus-TiefenbacherU , MaiSK , et al. Memory function before and after whole brain radiotherapy in patients with and without brain metastases. International Journal of Radiation Oncology* Biology* Physics2008;72(5):1311-8. [DOI: 10.1016/j.ijrobp.2008.03.009]">Welzel 2008</a>). In another study, patients with lung cancer receiving prophylactic cranial irradiation demonstrated declined cognitive functioning on subjective and objective measures at six‐ and 12‐month follow‐up assessments when compared to baseline scores (<a href="./references#CD011335-bbs2-0071" title="GondiV , PaulusR , BrunerDW , MeyersCA , GoreEM , WolfsonA , et al. Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of radiation therapy oncology group randomized trials 0212 and 0214. International Journal of Radiation Oncology* Biology* Physics2013;86(4):656-64. [DOI: 10.1016/j.ijrobp.2013.02.033]">Gondi 2013</a>). A randomised trial also documented significant cognitive deficits four months after whole brain radiotherapy (WBRT) compared to patients treated with radiosurgery alone (<a href="./references#CD011335-bbs2-0045" title="ChangEL , WefelJS , HessKR , AllenPK , LangFF , KornguthDG , et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncology2009;10(11):1037-44. [DOI: 10.1016/S1470-2045(09)70263-3]">Chang 2009</a>). </p> <section id="CD011335-sec-0010"> <h4 class="title">Neurotoxic effects of cranial irradiation</h4> <p>Radiation can be delivered to the brain tumour using large focused doses (stereotactic radiation), as part of standard fractionated treatments, or to the whole brain. Potential risk factors for cognitive decline following brain radiation include receiving fractionated radiation doses greater than 2 Gy (<a href="./references#CD011335-bbs2-0080" title="KleinM , HeimansJJ , van derPloegHM , GritJ , MullerM , PostmaTJ , et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet2002;360(9343):1361-8.">Klein 2002</a>), higher total radiation dose, larger brain volume of irradiation, using a divided‐dose schedule and longer overall treatment time (<a href="./references#CD011335-bbs2-0081" title="LeeAW , KwongDL , LeungSF , TungSY , SzeWM , ShamJST , et al. Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time. International Journal of Radiation Oncology* Biology* Physics2002;53(1):75-85. [DOI: 10.1016/S0360-3016(02)02711-6]">Lee 2002</a>). Other risk factors may include either combined or subsequent chemotherapy use, age, with those fewer than seven years or greater than 60 years old at higher risk, and comorbid vascular risk factors such as diabetes and hypertension (<a href="./references#CD011335-bbs2-0052" title="CrossenJR , GarwoodD , GlatsteinE , NeuweltEA . Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. Journal of Clinical Oncology1994;12(3):627-42.">Crossen 1994</a>; <a href="./references#CD011335-bbs2-0113" title="SzerlipN , RutterC , RamN , YovinoS , KwokY , MaggioW , et al. Factors impacting volumetric white matter changes following whole brain radiation therapy. Journal of Neuro-oncology2011;103(1):111-9. [PMID: 20725847]">Szerlip 2011</a>). In the identification of acute treatment‐related neurotoxicity it is important to distinguish symptoms from tumour progression, recurrence or metastases, since continuation of treatment may lead to irreversible central nervous system (CNS) injury (<a href="./references#CD011335-bbs2-0058" title="DietrichJ , MonjeM , WefelJ , MeyersC . Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist2008;13(12):1285-95. [DOI: 10.1634/thoncologist.2008-0130]">Dietrich 2008</a>). </p> <p>The neurotoxic effects of brain radiation have traditionally been divided into acute, early‐delayed and late‐delayed radiation encephalopathy (<a href="./references#CD011335-bbs2-0108" title="ShelineGE , WaraWM , SmithV . Therapeutic irradiation and brain injury. International Journal of Radiation Oncology* Biology* Physics1980;6(9):1215-28.">Sheline 1980</a>; <a href="./references#CD011335-bbs2-0128" title="WujantoC , VellayappanB , ChangEL , ChaoST , SahgalA , LoSS . Radiotherapy to the brain: what are the consequences of this age-old treatment?Ann Palliative Medicine2021;10(1):936-52.">Wujanto 2021</a>). Acute radiation encephalopathy occurs as a result of disruption to the blood‐brain barrier leading to accumulation of fluid in the tissue (vasogenic oedema). Corticosteroids are used at this stage, and may improve symptoms of drowsiness and headache, and prevent further neurologic decline. Early‐delayed radiation encephalopathy may occur at one to six months following completion of treatment, and symptoms of short‐term memory and attentional deficits are seen alongside drowsiness and worsening of pre‐existing neurological deficits. A return to baseline is often found within 12 months (<a href="./references#CD011335-bbs2-0120" title="ViglianiMC , SichezN , PoissonM , DelatrreJY . A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results. International Journal of Radiation Oncology* Biology* Physics1996;35(3):527-33.">Vigliani 1996</a>). This phase is associated with reversible damage to the myelin sheath (<a href="./references#CD011335-bbs2-0108" title="ShelineGE , WaraWM , SmithV . Therapeutic irradiation and brain injury. International Journal of Radiation Oncology* Biology* Physics1980;6(9):1215-28.">Sheline 1980</a>). In contrast to early complications, late‐delayed radiation encephalopathy is viewed as irreversible. This complication occurs months to years following radiation therapy and manifests as white matter lesions (i.e. leukoencephalopathy). In more severe forms it can manifest or lead to a formation of dead brain tissue which, as a result, can lead to a pressure effect and associated neurological dysfunction (<a href="./references#CD011335-bbs2-0061" title="FinkJ , BornD , ChamberlainMC . Radiation necrosis: relevance with respect to treatment of primary and secondary brain tumors. Current Neurology and Neuroscience Reports2012;12(3):276-85. [DOI: 10.1007/s11910-012-0258-7]">Fink 2012</a>).  </p> <p>The precise relationship between initial acute changes and late/chronic radiation damage to the brain is unknown. However, more recent evidence indicates that more subtle, early forms of radiation‐induced damage to the CNS could drive chronic pathophysiological processes leading to permanent cognitive decline (<a href="./references#CD011335-bbs2-0085" title="MakaleMT , McDonaldCR , Hattangadi-GluthJA , Kesari S. Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours.. Nature Reviews in Neurorology2017;13(1):52-64.">Makale 2017</a>). Clinically, late radiation damage is characterised by progressive mental slowing and impairment in attention and memory, with less commonly gait ataxia, urinary incontinence, apathy, and pyramidal and extrapyramidal signs (<a href="./references#CD011335-bbs2-0115" title="TaphoornMJ . Neurocognitive sequelae in the treatment of low-grade gliomas. Seminars in Oncology2003;30(6):45-8. [PMID: 14765385]">Taphoorn 2003</a>). The cognitive deficits increase in incidence and severity over time (<a href="./references#CD011335-bbs2-0080" title="KleinM , HeimansJJ , van derPloegHM , GritJ , MullerM , PostmaTJ , et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet2002;360(9343):1361-8.">Klein 2002</a>). However the exact incidence is hard to elucidate due to the large variety of neuropsychological tests used, the heterogeneous study populations and times at which patients are followed up (<a href="./references#CD011335-bbs2-0116" title="TaphoornMJ , KleinM . Cognitive deficits in adult patients with brain tumours. Lancet Neurology2004;3(3):159-68.">Taphoorn 2004</a>). Furthermore, deficits are likely to vary depending on the specific anatomic structures irradiated (<a href="./references#CD011335-bbs2-0074" title="Haldbo-ClassenL , AmidiA , LukacovaS , WuLM , OettingenGV , Lassen-RamshadY , et al. Cognitive impairment following radiation to hippocampus and other brain structures in adults with primary brain tumours. Radiotherapy and Oncology2020;148:1-7. [DOI: 10.1016/j.radonc.2020.03.023]">Haldbo‐Classen 2020</a>). Historical data indicate that up to 90% of adult brain tumour patients who survive for more than six months following WBRT therapy develop (some form of) cognitive impairment (<a href="./references#CD011335-bbs2-0052" title="CrossenJR , GarwoodD , GlatsteinE , NeuweltEA . Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. Journal of Clinical Oncology1994;12(3):627-42.">Crossen 1994</a>), and in up to 5% of long‐term survivors the cognitive impairment progresses to dementia necessitating admission to a nursing home (<a href="./references#CD011335-bbs2-0055" title="DeAngelisLM , DelattreJY , PosnerJB . Radiation-induced dementia in patients cured of brain metastases. Neurology1989;39(6):789. [DOI: 10.1212/WNL.39.6.789]">DeAngelis 1989</a>; <a href="./references#CD011335-bbs2-0120" title="ViglianiMC , SichezN , PoissonM , DelatrreJY . A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results. International Journal of Radiation Oncology* Biology* Physics1996;35(3):527-33.">Vigliani 1996</a>). The incidence of severe cognitive deficits/late delayed radiation encephalopathy has been shown to be even higher in patients with primary CNS lymphoma, reaching nearly 100% in patients older than 60 years old (<a href="./references#CD011335-bbs2-0039" title="AbreyLE , DeAngelisLM , YahalomJ . Long-term survival in primary CNS lymphoma. Journal of Clinical Oncology1998;16(3):859-63.">Abrey 1998</a>). However, improvements in treatments (including hippocampal‐sparing techniques and focal radiotherapy) are likely to have reduced the cognitive effects of radiotherapy treatment (<a href="./references#CD011335-bbs2-0128" title="WujantoC , VellayappanB , ChangEL , ChaoST , SahgalA , LoSS . Radiotherapy to the brain: what are the consequences of this age-old treatment?Ann Palliative Medicine2021;10(1):936-52.">Wujanto 2021</a>). Nevertheless, due to these adverse effects of cranial irradiation, the benefit of radiotherapy treatment for patients with a more favourable prognosis, such as with a low‐grade glioma (LGG), or as prophylactic cranial irradiation for small cell lung carcinoma, has been the subject of much debate in the past decade (<a href="./references#CD011335-bbs2-0071" title="GondiV , PaulusR , BrunerDW , MeyersCA , GoreEM , WolfsonA , et al. Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of radiation therapy oncology group randomized trials 0212 and 0214. International Journal of Radiation Oncology* Biology* Physics2013;86(4):656-64. [DOI: 10.1016/j.ijrobp.2013.02.033]">Gondi 2013</a>; <a href="./references#CD011335-bbs2-0129" title="XueS , ZengH , YanS , WangQ , Jia X. Prophylactic cranial irradiation for extensive-stage small-cell lung cancer: A controversial area. Frontiers in Oncology2022;12:772282.">Xue 2022</a>). </p> </section> <section id="CD011335-sec-0011"> <h4 class="title">The mechanisms of cranial irradiation‐induced cognitive impairment</h4> <p>The mechanisms by which radiation causes cognitive decline have been proposed to include microvascular damage, oligodendrocyte decline, loss of white matter integrity, neuroinflammation, metabolic changes, and neuronal dendritic spike damage (<a href="./references#CD011335-bbs2-0085" title="MakaleMT , McDonaldCR , Hattangadi-GluthJA , Kesari S. Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours.. Nature Reviews in Neurorology2017;13(1):52-64.">Makale 2017</a>; <a href="./references#CD011335-bbs2-0097" title="PazzagliaS , BrigantiG , MancusoM , SaranA . Neurocognitive decline following radiotherapy: mechanisms and therapeutic implications. Cancers (Basel)2020;12(1):146.">Pazzaglia 2020</a>; <a href="./references#CD011335-bbs2-0111" title="SultanaN , SunC , KatsubeT , WangB . Biomarkers of brain damage induced by radiotherapy. Dose Response2020;18(3):1559325820938279.">Sultana 2020</a>). Long‐term radiation‐induced cognitive decline is likely to reflect changes to the white matter, hippocampus and prefrontal cortex, as well as other areas (<a href="./references#CD011335-bbs2-0085" title="MakaleMT , McDonaldCR , Hattangadi-GluthJA , Kesari S. Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours.. Nature Reviews in Neurorology2017;13(1):52-64.">Makale 2017</a>). Two of the most studied mechanisms of radiation‐induced cognitive impairment include white matter changes and impaired neurogenesis.  </p> <p>The primary mechanism of delayed radiation‐induced white matter changes is associated with secondary endothelial damage and microvascular ischaemic insult (<a href="./references#CD011335-bbs2-0084" title="LyubimovaN , HopewellJW . Experimental evidence to support the hypothesis that damage to vascular endothelium plays the primary role in the development of late radiation-induced CNS injury. British Journal of Radiology2004;77(918):488-92. [PMID: 15151969]">Lyubimova 2004</a>), accompanied by apoptosis (programmed cell death) of oligodendrocyte progenitors (<a href="./references#CD011335-bbs2-0085" title="MakaleMT , McDonaldCR , Hattangadi-GluthJA , Kesari S. Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours.. Nature Reviews in Neurorology2017;13(1):52-64.">Makale 2017</a>). This leads to a decrease in the volume of cerebral white matter, which is directly associated with cognitive decline (<a href="./references#CD011335-bbs2-0050" title="CorreaDD , DeAngelisLM , ShiW , ThalerH , GlassA , AbreyLE . Cognitive functions in survivors of primary central nervous system lymphoma. Neurology2004;62(4):548-55. [PMID: 14981169]">Correa 2004</a>; <a href="./references#CD011335-bbs2-0095" title="MulhernRK , MerchantTE , GajjarA , ReddickWE , KunLE . Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncology2004;5(7):399-408.">Mulhern 2004</a>; <a href="./references#CD011335-bbs2-0102" title="ReddickWE , ShanZY , GlassJO , HeltonS , XiongX , WuS , et al. Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer2006;106(4):941-9. [PMID: 16411228]">Reddick 2006</a>). This has been confirmed in a longitudinal study that found medulloblastoma patients receiving a cranial irradiation dose of 36 Gy to show more rapid cerebral white matter volume decrease than those receiving a cranial irradiation dose of 23.4 Gy (<a href="./references#CD011335-bbs2-0096" title="PalmerSL , ReddickWE , GlassJO , GajjarA , GoloubevaO , MulhernRK . Decline in corpus callosum volume among pediatric patients with medulloblastoma: longitudinal MR imaging study. American Journal of Neuroradiology2002;23(7):1088-94. [PMID: 12169462]">Palmer 2002</a>). Rarely, these white matter lesions can increase in size and may progress to frank white matter necrosis characterised by focal cavitations in the white matter within the radiated fields (<a href="./references#CD011335-bbs2-0040" title="AnscherMS , SwiftPS , GasparLE , MarksLB . Radiation injury of the brain and spinal cord. In: WilkinsRH , RengacharySS , editors(s). Neurosurgery. New York: McGraw-Hill, 1996:1921-36.">Anscher 1991</a>). Treatment of radionecrosis involves surgical excision and steroid therapy, and studies using bevacizumab, an angiogenesis inhibitor, have also reported high rates of clinical and radiological responses, albeit with small sample sizes (<a href="./references#CD011335-bbs2-0073" title="GonzalesJ , KumarAJ , ConradCA , LevinVA . Effect of bevacizumab on radiation necrosis of the brain. International Journal of Radiation Oncology* Biology* Physics2007;67(2):323-6. [DOI: 10.1016/j.ijrobp.2006.10.010]">Gonzales 2007</a>; <a href="./references#CD011335-bbs2-0022" title="LevinVA , BidautL , HouP , KumarAJ , WefelJS , BekeleBN , et al. Randomized double‐blind placebo‐controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. International Journal of Radiation Oncology *Biology *Physics2011;79(5):1487-95. ">Levin 2011</a>; <a href="./references#CD011335-bbs2-0117" title="TorcuatorR , ZunigaR , MohanYS , RockJ , DoyleT , Anderson J et al. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. Journal of Neuro-oncology2009;94(1):63-8.">Torcuator 2009</a>; <a href="./references#CD011335-bbs2-0123" title="WangY , PanL , ShengX , MaoY , YaoY , Wany E et al. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients. European Journal of Medical Research2012;17(1):25. [DOI: 10.1186/2047-783X-17-25]">Wang 2012</a>). </p> <p>Neurogenesis refers to the birth of new neurons, and occurs through the division of neural stem cells and subsequent maturation into neural progenitor cells that migrate and mature into neurons (<a href="./references#CD011335-bbs2-0063" title="GageFH . Adult neurogenesis in mammals. Science2019;364(6443):827-8.">Gage 2019</a>). There exists compelling molecular evidence of the occurrence of neurogenesis throughout the human lifespan (<a href="./references#CD011335-bbs2-0130" title="ZhouY , SuY , LiS , KennedyBC , ZhangDY , BondAM , et al. Molecular landscapes of human hippocampal immature neurons across lifespan. Nature2022;607(7919):527-33.">Zhou 2022</a>). A post‐mortem study in patients with medulloblastoma found significantly lower neurogenesis in patients treated with radiotherapy two to 23 years prior to analysis, compared to controls matched for age and sex (<a href="./references#CD011335-bbs2-0092" title="MonjeML , VogelH , MasekM , LigonKL , FisherPG , PalmerTD . Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies. Annals of Neurology2007;62(5):515-20. [DOI: 10.1002/ana.21214]">Monje 2007</a>). Radiotherapy strategies that attempt to spare the crucial areas of neurogenesis, including the hippocampus, have been shown in several studies to result in improved cognition relative to conventional radiotherapy techniques (<a href="./references#CD011335-bbs2-0072" title="GondiV , PughSL , TomeWA , CaineC , CornB , KannerA , et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. Journal of Clinical Oncology2014;32(34):3810-6.">Gondi 2014</a>; <a href="./references#CD011335-bbs2-0078" title="KimKS , WeeCW , SeokJY , HongJW , ChungJB , EomKY , et al. Hippocampus-sparing radiotherapy using volumetric modulated arc therapy (VMAT) to the primary brain tumor: the result of dosimetric study and neurocognitive function assessment. Radiation Oncology2018;13(1):29.">Kim 2018</a>), including a phase III randomised controlled trial (<a href="./references#CD011335-bbs2-0043" title="BrownPD , GondiV , PughS , TomeWA , WefelJS , ArmstrongTS , e al, for NRG Oncology. Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with Brain Metastases: phase III trial NRG Oncology CC001. Journal of Clinical Oncology2020;38(10):1019-29.">Brown 2020</a>). </p> </section> <section id="CD011335-sec-0012"> <h4 class="title">Measuring cognitive deficits</h4> <p>Use of a core battery of validated neuropsychological tests to assess cognitive function have been recommended in order to harmonise studies of cognitive function in patients with cancer (<a href="./references#CD011335-bbs2-0125" title="WefelJS , VardyJ , AhlesT , SchagenSB . International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncology2011;12(7):703-8. [DOI: 10.1016/S1470-2045(10)70294-1]">Wefel 2011</a>). These include the Hopkins Verbal Learning Test‐Revised (HVLT‐R) (<a href="./references#CD011335-bbs2-0041" title="BenedictRH , SchretlenD , GroningerL , BrandtJ . Hopkins Verbal Learning Test-revised: normative data and analysis of inter-form and test-retest reliability. Clinical Neuropsychologist1998;12(1):43-55.">Benedict 1998</a>) to assess learning and memory, Trail Making Test (TMT) (<a href="./references#CD011335-bbs2-0103" title="ReitanRM . Trail making test manual for administration and scoring. Reitan Neuropsychology Laboratory, Tucson1989.">Reitan 1992</a>) to assess processing speed and executive function, and the Controlled Oral Word Association test of the Multilingual Aphasia Examination (COWA) (<a href="./references#CD011335-bbs2-0042" title="BentonAL , HamsherKS . Multilingual Aphasia Examination. Iowa City, IA, AJA Associates1989.">Benton 1989</a>) to assess verbal fluency. Other tests have also been used, such as digit span and digit symbol (<a href="./references#CD011335-bbs2-0124" title="Wechsler. Wechsler Adult Intelligence Scale-Revised. Psychological Corporation, San Antonio1981.">Wechsler 1981</a>) to assess working memory and information processing speed, respectively. Cognitive function has also been assessed by using brief mental status evaluations, such as the Mini‐Mental State Examination (MMSE) (<a href="./references#CD011335-bbs2-0062" title='FolsteinMF , FolsteinSE , McHughPR . "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research1975;12(3):189-98.'>Folstein 1975</a>). Whilst the MMSE is often shorter than neuropsychological testing, it has been associated with poor sensitivity in detecting cognitive deficits (<a href="./references#CD011335-bbs2-0088" title="MeyersCA , WefelJS . The use of the Mini-Mental State Examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. Journal of Clinical Oncology2003;21(19):3557-8.">Meyers 2003</a>). Other studies have used subjective patient reports of cognitive concerns, such as in memory and concentration (<a href="./references#CD011335-bbs2-0083" title="LidstoneV , ButtersE , SeedPT , SinnottC , BeynonT , RichardsM . Symptoms and concerns amongst cancer outpatients: identifying the need for specialist palliative care. Palliative Medicine2003;17(7):588-95.">Lidstone 2003</a>; <a href="./references#CD011335-bbs2-0094" title="MukandJA , BlackintonDD , CrincoliMG , LeeJJ , SantosBB . Incidence of neurologic deficits and rehabilitation of patients with brain tumors. American Journal of Physical Medicine &amp; Rehabilitation2001;80(5):346-50.">Mukand 2001</a>). An additional consistent finding from the research literature is that correlations between subjectively assessed cognitive symptoms and objectively determined cognitive functioning are quite modest, with correlation coefficients generally ranging from 0.20 to 0.30 (<a href="./references#CD011335-bbs2-0080" title="KleinM , HeimansJJ , van derPloegHM , GritJ , MullerM , PostmaTJ , et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet2002;360(9343):1361-8.">Klein 2002</a>). These are suggested to be confounded by some patients' lack of awareness regarding their cognitive impairments, and correlations with fatigue and depression, rather than cognitive test performance (<a href="./references#CD011335-bbs2-0053" title="CullA , HayC , LoveSB , MackieM , SmetsE , StewartM . What do cancer patients mean when they complain of concentration and memory problems?British Journal of Cancer1996;74(10):1674-9.">Cull 1996</a>; <a href="./references#CD011335-bbs2-0067" title="GehringK , TaphoornMJ , SitskoornMM , AaronsonNK . Predictors of subjective versus objective cognitive functioning in patients with stable grades II and III glioma. Neurooncology Practice2015;2(1):20-31.">Gehring 2015</a>). </p> <p>To evaluate intervention effects, repeated neuropsychological testing is employed. However, practice effects occur resulting in improved test performance (<a href="./references#CD011335-bbs2-0059" title="DuffK , CallisterC , DennettK , TometichD . Practice effects: a unique cognitive variable.. Clinical Neuropsychology2012;26(7):1117-27.">Duff 2012</a>). As a consequence, improvement (or stability) of test scores may be unjustly attributed to the intervention, where perhaps patients would otherwise have demonstrated a decline over time ‐ which is not uncommon in patients with brain tumours). In preventative and ameliorative intervention trials, practice effects should thus be accounted for. The variations in tools available, use of both objective and subjective measures, differences in time points at which cognitive functioning is measured and the differences in intervention duration highlight the caution that must be taken when combining and generalising results and conclusions. </p> </section> </section> <section id="CD011335-sec-0013"> <h3 class="title" id="CD011335-sec-0013">Description of the intervention</h3> <p> This review included all studies on interventions that aim to:</p> <p> <ul id="CD011335-list-0001"> <li> <p>prevent, or</p> </li> <li> <p>ameliorate</p> </li> </ul> </p> <p>any cognitive deficits in people who have received therapeutic or prophylactic cranial irradiation prior to, or during, participation in the study. These may include pharmacological and non‐pharmacological (medical, psychological or behavioural) interventions for the management of cognitive deficits. It is worth noting, however, that it is likely that almost all patients in the 'prevention' studies will have deficits in at  least one cognitive domain, most commonly in memory and verbal fluency, due to the tumour or possibly prior neurosurgical intervention. A large proportion of patients will have been on steroid therapy and some may be recovering from craniotomy. Thus the distinction between 'prevention' and 'amelioration' is not clear cut. </p> <section id="CD011335-sec-0014"> <h4 class="title">Pharmacological</h4> <p>We defined pharmacological interventions as a drug, including herbs, given by any route at any therapeutic dose with the intention of preventing or ameliorating cognitive deficits in persons who have received cranial irradiation. </p> <p>Studies investigating the pharmacological prevention of cognitive impairment have frequently been conducted in patients undergoing cranial irradiation during participation. For example, memantine, used in the treatment of Alzheimer's Disease (<a href="./references#CD011335-bbs2-0105" title="RobinsonDM , KeatingGM . Memantine: a review of its use in Alzheimer's disease. Drugs2006;66(11):1515-34. [PMID: 16906789]">Robinson 2006</a>), has been investigated for its neuroprotective role during irradiation. </p> <p>Studies of pharmacological treatment for cognitive impairment after cranial irradiation have largely focused on psychostimulants, including methylphenidate (<a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>, <a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>) and modafinil (<a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>, <a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a>). Objective cognitive functioning and patient‐reported outcomes of fatigue, mood and quality of life have been used to assess the efficacy of methylphenidate and modafinil in patients with brain tumour, 83% of whom had received cranial irradiation (<a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>). Donepezil (<a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a>, <a href="./references#CD011335-bbs2-0032" title="ShawEG , RosdhalR , D'Agostino RB Jr, LovatoJ , NaughtonMJ , RobbinsME , et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. Journal of Clinical Oncology2006;24(9):1415-20. ">Shaw 2006</a>) and memantine (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>), used in the treatment of Alzheimer's Disease, have also been investigated for their use in the treatment/prevention of cognitive symptoms in brain‐irradiated adults. Although the pharmacological mechanism of action is widely assumed to be through 'prevention' of cognitive failure rather than the treatment of existing cognitive impairments, the effect of drugs used in this setting is unclear and may have a 'treatment effect' as well as a 'preventative effect' in slowing the progression of cognitive failure. Chinese medicinal herbs and dietary supplements have also been investigated in irradiated brain tumour patients (<a href="./references#CD011335-bbs2-0009" title="AttiaA , RappSR , CaseLD , D'AgostinoR , LesserG , NaughtonM , et al. Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood. Journal of Neuro-oncology2012;109:357-63. [DOI: 10.1007/s11060-012-0901-9]">Attia 2012</a>).  </p> </section> <section id="CD011335-sec-0015"> <h4 class="title">Non‐pharmacological</h4> <p>We defined non‐pharmacological interventions as any non‐drug intervention given with the intention of ameliorating or preventing cognitive deficits during or following cranial irradiation. These can include, but are not limited to, medical, psychological and behavioural interventions. </p> <p>Medical interventions include any biomedical intervention given to a person in which the intervention is not primarily investigating cancer treatment or control. For example, one study explored the use of hyperbaric oxygen therapy in cranial irradiated brain tumour patients using 31 neuropsychological tests (<a href="./references#CD011335-bbs2-0019" title="HulshofMCC , StarkNM , van derKleijA , SminiaP , SmedingHM , GonzalezDG . Hyperbaric oxygen therapy for cognitive disorders after irradiation of the brain [Hyperbare oxygenierung bei patienten mit kognitiven störungen nach hirnbestrahlung]. Strahlentherapie und Onkologie2002;178(4):192-8. [DOI: 10.1007/s00066-002-0916-9]">Hulshof 2002</a>). </p> <p>Psychological interventions may include (but are not limited to) education, retraining and compensation strategies. Several studies have evaluated cognitive rehabilitation in patients with brain tumours (<a href="./references#CD011335-bbs2-0016" title="GehringK , SitskoornMM , GundyCM , SikkesSA , KleinM , PostmaTJ , et al. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. Journal of Clinical Oncology2009;27(22):3712-22. [DOI: 10.1200/JCO.2008.20.5765]">Gehring 2009</a>, <a href="./references#CD011335-bbs2-0005" title="LockeDEC , CerhanJH , WuW , MalecJF , ClarkMM , Rummans TA, et al. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumours: a pilot study. Journal of Supportive Oncology2008;6(8):383-91. ">Locke 2008</a>, <a href="./references#CD011335-bbs2-0007" title="RichardNM , BernsteinLJ , MasonWP , LaperriereN , MauriceC , MillarBA , et al. Cognitive rehabilitation for executive dysfunction in brain tumor patients: a pilot randomized controlled trial. Journal of Neuro oncology2019;142(3):565-75. [DOI: 10.1007/s11060-019-03130-1]">Richard 2019</a>).  </p> <p>Behavioural interventions can include exercise (<a href="./references#CD011335-bbs2-0018" title="GehringK , StuiverMM , VisserE , KloekC , vanden BentM , HanseM , et al. A pilot randomized controlled trial of exercise to improve cognitive performance in patients with stable glioma: a proof of concept. Neuro Oncology2020;22(1):103-15. ">Gehring 2020</a>) as well as behavioural modification interventions such as mindfulness and dietary interventions. </p> </section> </section> <section id="CD011335-sec-0016"> <h3 class="title" id="CD011335-sec-0016">How the intervention might work</h3> <p>Clinical trials have explored the prevention and treatment of cognitive deficits by targeting pharmacological, psychological or behavioural pathways. </p> <section id="CD011335-sec-0017"> <h4 class="title">Pharmacological</h4> <p>Pharmacological interventions may prevent cognitive deficits via their neuroprotective role during WBRT such as memantine, an N‐Methyl‐D‐aspartate receptor antagonist (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>). </p> <p>Pharmacological interventions may ameliorate cognitive deficits via their involvement in critical neurotransmitter pathways. Methylphenidate is a CNS stimulant found to have a positive effect on attention due to its action on the brain centre for attention control, the fronto‐striatal network, by increasing dopamine and noradrenaline concentrations (<a href="./references#CD011335-bbs2-0121" title="VolkowND , FowlerJS , WangG , DingY , GatleySJ . Mechanism of action of methylphenidate: insights from PET imaging studies. Journal of Attention Disorders2002;6:S31-43.">Volkow 2002</a>). Another centrally acting drug is donepezil, a reversible cholinesterase inhibitor involved in inhibiting the breakdown of the neurotransmitter acetylcholine, often prescribed for patients with Alzheimer's Disease. This may have a cognitive enhancing effect by prolonging and improving cholinergic function, associated with learning and memory (<a href="./references#CD011335-bbs2-0110" title="SteinbergM , LyketsosCG . Pharmacological therapies in Alzheimer's disease. In: Abou-SalehMT , KatonaC , KumarA , editors(s). Principles and Practice of Geriatric Psychiatry. 3rd edition. Oxford: John Wiley &amp; Sons, 2010. [DOI: 10.1002/9780470669600.ch52]">Steinberg 2011</a>). </p> </section> <section id="CD011335-sec-0018"> <h4 class="title">Non‐pharmacological</h4> <p>Medical interventions have also been considered to help prevent or treat cognitive deficits. Hyperbaric oxygen therapy has been used to improve damage to the nervous system by stimulating angiogenesis, the process through which new blood vessels are formed from pre‐existing blood vessels (<a href="./references#CD011335-bbs2-0068" title="GillAL , BellCN . Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM: an International Journal of Medicine2004;97(7):385-95. [DOI: 10.1093/qjmed/hch074]">Gill 2004</a>). </p> <p>Psychological interventions may help prevent and improve cognitive deficits by retraining cognitive capacities such as attention and memory, or via compensation strategies such as memory aids. These interventions target the plasticity of the brain, via restoration or reorganisation of function (<a href="./references#CD011335-bbs2-0089" title="MiottoEC , SavageCR , EvansJJ , WilsonBA , MartinMG , BalardinJB , et al. Semantic strategy training increases memory performance and brain activity in patients with prefrontal cortex lesions. Clincal Neurology and Neurosurgery2013;115(3):309-16.">Miotto 2013</a>; <a href="./references#CD011335-bbs2-0093" title="MoraF . Successful brain aging: plasticity, environmental enrichment, and lifestyle. Dialogues in Clinical Neuroscience2013;15(1):45-52. [PMID: PMC3622468]">Mora 2013</a>). For example, <a href="./references#CD011335-bbs2-0046" title="CiceroneKD , LangenbahnDM , BradenC , MalecJF , KalmarK , FraasM , et al. Evidence-based cognitive rehabilitation: updated review of the literature from 2003 through 2008. Archives of Physical Medicine and Rehabilitation2011;92(4):519-30.">Cicerone 2011</a> reviewed 370 cognitive rehabilitation interventions and found supportive evidence for its role in patients with traumatic brain injury and stroke. </p> <p>Behavioural interventions, such as exercise, may also help ameliorate or prevent cognitive deficits. Exercise has been associated with increases in cerebral blood flow, increased hippocampal neurogenesis, changes in neurotransmitter release and arousal levels and brain structure, and particularly through the involvement of Brain Derived Neurotrophic Factor associated with nerve growth (<a href="./references#CD011335-bbs2-0070" title="GligoroskaJP , ManchevskaS . The effect of physical activity on cognition - physiological mechanisms. Materia Socio Medica2012;24(3):198-202. [PMID: PMC363396]">Gligoroska 2012</a>). </p> <p>Other non‐pharmacological interventions, such as those involving diet modifications, may also play a role in improving cognitive functioning. The dietary supplement <i>Ginkgo biloba</i> has been associated with regulating signalling pathways, cellular metabolism and gene transcription (<a href="./references#CD011335-bbs2-0109" title="SmithJV , LuoY . Studies on molecular mechanisms of Ginkgo biloba extract. Applied Microbiology and Biotechnology2004;64(4):465-72. [DOI: 10.1007/s00253-003-1527-9]">Smith 2003</a>). </p> </section> </section> <section id="CD011335-sec-0019"> <h3 class="title" id="CD011335-sec-0019">Why it is important to do this review</h3> <p>As anti‐cancer treatments become more effective and readily available across treatment centres, patients live longer disease‐free, but with long‐term sequelae of the disease and the neurotoxic side effects of treatment (<a href="./references#CD011335-bbs2-0047" title="CochranDC , ChanMD , AkliluM , LovatoJF , AlphonseNK , BourlandJD , et al. The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery. Journal of Neurosurgery2012;116(5):978-83. [DOI: 10.3171/2012.2.JNS111353]">Cochran 2012</a>). Greater emphasis is now being placed on quality of life and with the establishment of neurocognitive function as a predictor of survival (<a href="./references#CD011335-bbs2-0087" title="MeyersCA , HessKR , YungWA , LevinVA . Cognitive function as a predictor of survival in patients with recurrent malignant glioma. Journal of Clinical Oncology2000;18(3):646.">Meyers 2000</a>; <a href="./references#CD011335-bbs2-0119" title="vanKesselE , Huenges WajerIM , RuisC , SeuteT , FonvilleS , De VosFYF , et al. Cognitive impairments are independently associated with shorter survival in diffuse glioma patients. Journal of Neurology2021;268(4):1434-42.">van Kessel 2021</a>) and quality of life (<a href="./references#CD011335-bbs2-0091" title="MitchellAJ , KempS , Benito-LeónJ , ReuberM . The influence of cognitive impairment on health-related quality of life in neurological disease. Acta Neuropsychiatrica2010;22(1):2-13. [DOI: 10.1111/j.1601-5215.2009.00439.x]">Mitchell 2010</a>), cognitive functioning is an essential outcome measure. There is currently no standard policy to direct treatment. With even mild cognitive impairment leading to negative functional and psychiatric consequences, especially if persistent and untreated, it is important to identify ways to reduce the long‐term impact of cranial irradiation on neuropsychological function. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011335-sec-0020" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011335-sec-0020"></div> <p>To assess the effectiveness of interventions for preventing or ameliorating cognitive deficits in adults treated with cranial irradiation. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011335-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011335-sec-0021"></div> <section id="CD011335-sec-0022"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011335-sec-0023"> <h4 class="title">Types of studies</h4> <p>We searched for randomised trials (including those described in conference abstracts) that included: (i) a group receiving an intervention for cognitive function; and (ii) a control group or comparison group receiving no intervention for cognitive function, standard care, or a comparison with a normative data control group, or comparison to another active intervention. </p> </section> <section id="CD011335-sec-0024"> <h4 class="title">Types of participants</h4> <section id="CD011335-sec-0025"> <h5 class="title">Prevention</h5> <p>For studies investigating the prevention of cognitive deficits, we included studies that involved adult patients (aged 18 years and over) who received an intervention aimed at the prevention of cognitive deficits and underwent cranial irradiation (whole brain or partial brain radiation) during participation in the study, for the treatment of primary or secondary brain cancer, or prophylactic treatment for other cancers. </p> <p>Since these studies refer to interventions for <i>preventing</i> cognitive deficits, the presence of cognitive deficits at baseline was not an inclusion criterion. However, we only included studies where cognitive functioning was assessed via neuropsychological testing both prior to and following the start of the intervention. </p> </section> <section id="CD011335-sec-0026"> <h5 class="title">Amelioration</h5> <p>For studies investigating the amelioration of cognitive deficits, we included studies that involved adult patients (aged 18 years and over) with impairment in at least one cognitive domain, who received an intervention aiming to ameliorate cognitive deficits and had previously undergone cranial irradiation (whole brain or partial brain radiation) prior to participation in the study for the treatment of primary or secondary brain cancer, or prophylactic treatment for other cancers. Cognitive impairment was determined prior to participation via neuropsychological testing. Participants could have received cranial irradiation during childhood, but had to be an adult (aged 18 years and over) during participation in the study.  </p> <p>We also included studies that involved only a subset of patients who had undergone cranial irradiation in the review, if this group formed a large majority (&gt; 80%) of the study population or had been explored via subgroup analyses. </p> </section> </section> <section id="CD011335-sec-0027"> <h4 class="title">Types of interventions</h4> <p>Studies that were included could have utilised pharmacological (e.g. stimulants, or neuroprotective agents) or medical (e.g. hyperbaric oxygen therapy) approaches, or psychological (e.g. cognitive rehabilitation) or behavioural (e.g. exercise) interventions, targeted to prevent or ameliorate radiation‐related cognitive deficits. </p> <p>Whilst we included studies that investigated the preventative role of an intervention during cranial irradiation, we did not include those where the intervention being investigated was cranial irradiation itself, associated with treating the tumour or improving tumour control. Such excluded studies included those on: </p> <p> <ul id="CD011335-list-0002"> <li> <p>hippocampal sparing techniques;</p> </li> <li> <p>techniques limiting radiation dosage to healthy tissue (e.g. intensity‐modulated radiation therapy); </p> </li> <li> <p>the addition of chemotherapy agents (e.g. motexafin gadolinium).</p> </li> </ul> </p> <p>Although these techniques can be associated with reduced or limited cognitive side effects, these techniques would best fit a separate Cochrane systematic review investigating the effect of dose of radiotherapy in causing cognitive problems. </p> <section id="CD011335-sec-0028"> <h5 class="title">Pharmacological interventions</h5> <p>We investigated the effectiveness of any drug or herb given by any route for any duration, and at any therapeutic dose, with the objective of preventing or treating cognitive deficits in patients who had received, or were receiving, cranial irradiation. Such drugs are likely to include psychostimulants (e.g. methylphenidate, modafinil), and might include drugs to treat cognitive deficits in other neurological conditions (e.g. donepezil, memantine).  </p> <p>For ethical reasons, studies involving drugs may not automatically include a placebo arm. To increase the relevance of the review we included studies without a placebo arm if the study involved a group of participants who have been randomised to a control group of some kind (e.g. treatment as usual, another active drug or allocation to a waiting list), or that have been compared to normative control data with correction of practice effects caused by repeated neuropsychological testing. </p> </section> <section id="CD011335-sec-0029"> <h5 class="title">Non‐pharmacological interventions</h5> <p>For non‐drug medical interventions, we investigated any medical intervention, such as hyperbaric oxygen therapy, which aimed to prevent or improve cognitive deficits in patients who had received, or were receiving, cranial irradiation. </p> <p>For psychological and behavioural interventions, we reviewed any cognitive and/or behavioural treatment given with the intention or preventing or treating cognitive deficits in patients who had received, or were receiving, cranial irradiation; these could include, but were not limited to, retraining, education or teaching of compensation strategies, physical exercise interventions or dietary supplements. Due to the nature of these interventions, it can be difficult to blind different arms of trials. To increase the relevance of the review we included studies without a placebo arm if the study involved a group of participants who have been randomised to a control group of some kind (e.g. treatment as usual, another active treatment or allocation to a waiting list), or that have been compared to normative control data with correction of practice effects caused by repeated neuropsychological testing. </p> </section> </section> <section id="CD011335-sec-0030"> <h4 class="title">Types of outcome measures</h4> <section id="CD011335-sec-0031"> <h5 class="title">Primary outcomes</h5> <p>The primary outcome for this review was cognitive performance as assessed by neuropsychological tests (and not self‐report); this could be a general or composite cognitive score or individual cognitive test scores using validated neuropsychological tests (e.g. Hopkins Verbal Learning Test‐Revised (HVLT‐R (HVLT‐R), Controlled Oral Word Association Test (COWA)). Cognitive functioning had to be measured at baseline and following intervention at any time point. </p> <p>In studies involving preventative interventions, we determined efficacy as a statistically significant improvement in cognitive functioning, or no change/decline from baseline. Studies could have objective cognitive functioning as a primary outcome or include cognitive performance as the secondary outcome to an alternative primary quality of life measure (e.g. fatigue, mood). </p> <p>In studies involving ameliorating interventions, we determined efficacy as a statistically significant improvement, or no change, in cognitive functioning from baseline. To increase the relevance of the review, we did not restrict eligible studies with respect to the time point at which cognitive functioning was measured at baseline or at follow‐up. We noted and discussed the time points at which cognitive functioning was measured. </p> </section> <section id="CD011335-sec-0032"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD011335-list-0003"> <li> <p>Self‐reported cognitive functioning via interviews or questionnaires.</p> </li> <li> <p>General functioning including mood/psychiatric symptoms (e.g. Hospital Anxiety and Depression Scale (HADS)), self‐reported fatigue (e.g. Brief Fatigue Inventory (BFI)) and quality of life measurements (e.g. FACT‐Br). </p> </li> <li> <p>Adverse events (e.g. nausea, skin reactions, headache).</p> </li> </ul> </p> <p>We noted and reviewed the secondary outcomes if recorded, but these were not eligibility criteria for this review. </p> </section> </section> </section> <section id="CD011335-sec-0033"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011335-sec-0034"> <h4 class="title">Electronic searches</h4> <p>For this review update, we searched the following databases up to 12 September 2022:</p> <p> <ul id="CD011335-list-0004"> <li> <p>Cochrane Register of Controlled Trials (CENTRAL, 2022, Issue 9), in the Cochrane Library;</p> </li> <li> <p>MEDLINE via Ovid (August 2014 to September 11 2022);</p> </li> <li> <p>Emase via Ovid (August 2014 to 2022 week 36);</p> </li> <li> <p>PsycInfo via Ovid (August 2014 to 12 September 2022).</p> </li> </ul> </p> <p>The search strategies are listed in <a href="./appendices#CD011335-sec-0109">Appendix 1</a> (MEDLINE), <a href="./appendices#CD011335-sec-0110">Appendix 2</a> (Embase), <a href="./appendices#CD011335-sec-0111">Appendix 3</a> (CENTRAL), and <a href="./appendices#CD011335-sec-0112">Appendix 4</a> (PsycINFO). The search strategies were not restricted by year of publication, language or publication type. Following de‐duplication the references were run through the Cochrane 'RCT Classifier' to identify records more than 10% likely to be a randomised controlled trial ( RCT). </p> <p><i>Original Searches</i> </p> <p>The original searches for the review of 'Interventions for preventing and ameliorating cognitive deficits in adults treatment with cranial irradiation' (<a href="./references#CD011335-bbs2-0133" title="DayJ , ZieniusK , GehringK , GrosshansD , TaphoornM , GrantR , LiJ , BrownPD . Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation. Cochrane Database of Systematic Reviews2014, Issue 12. Art. No: CD011335. [DOI: 10.1002/14651858.CD011335.pub2]">Day 2014b</a>) were as follows: </p> <p> <ul id="CD011335-list-0005"> <li> <p>Cochrane Register of Controlled Trials (CENTRAL, 2014, Issue 8);</p> </li> <li> <p>MEDLINE (1950 to August 2014);</p> </li> <li> <p>Embase (1980 to August 2014);</p> </li> <li> <p>PsycINFO (1974 to August 2014).</p> </li> </ul> </p> </section> <section id="CD011335-sec-0035"> <h4 class="title">Searching other resources</h4> <p> <ul id="CD011335-list-0006"> <li> <p>We searched the reference lists of included studies.</p> </li> <li> <p>We searched for ongoing trials using ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>), the Physicians Data Query (<a href="http://www.cancer.gov/clinicaltrials" target="_blank">www.cancer.gov/clinicaltrials</a>) and the <i>meta</i>Register of Controlled Trials (<a href="http://www.controlled-trials.com/mrct" target="_blank">www.controlled-trials.com/mrct</a>). </p> </li> </ul> </p> </section> </section> <section id="CD011335-sec-0036"> <h3 class="title" id="CD011335-sec-0036">Data collection and analysis</h3> <section id="CD011335-sec-0037"> <h4 class="title">Selection of studies</h4> <p>We used the reference management database EndNote to download all titles and abstracts retrieved by electronic searching. We removed duplicates and two review authors (MK, JD) independently examined the remaining references. The review authors were not blinded to the authors or affiliations of the studies. We obtained full‐text copies of potentially relevant references and excluded studies clearly not meeting the inclusion criteria. Two review authors (MK, JD) independently assessed the eligibility of retrieved papers, with disagreements planned to be resolved by discussion with a third review author (KG), which was not necessary. We documented reasons for the exclusion of studies. </p> </section> <section id="CD011335-sec-0038"> <h4 class="title">Data extraction and management</h4> <section id="CD011335-sec-0039"> <h5 class="title">Data extraction</h5> <p>We used the recommendations from the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> to extract data from included trials using a data extraction form specifically designed for this review (<a href="./references#CD011335-bbs2-0076" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). Two review authors (MK, JD) completed data extraction independently. Differences between review authors were resolved by discussion. </p> <p>Data extracted included the following:</p> <p> <ul id="CD011335-list-0007"> <li> <p>article details (author, year of publication, journal, country and language);</p> </li> <li> <p>aim of the study (preventative or ameliorative);</p> </li> <li> <p>methodology (study design, participant recruitment method, inclusion and exclusion criteria, informed consent, ethical approval, statistical analyses including corrections for practice effects); </p> </li> <li> <p>population demographics (geographical location, setting, age, gender, ethnicity, total number included in trial and analyses); </p> </li> <li> <p>details of participants health status (including disease status, tumour pathology, tumour treatment details including proportion receiving radiotherapy, antiepileptic medication, corticosteroid use); </p> </li> <li> <p>intervention (characteristics such as drug dose, preparation and route of administration, frequency and duration, detail of providers, timing of intervention in relation to radiotherapy); </p> </li> <li> <p>outcomes (primary and secondary outcomes assessed, method and timing of assessments);</p> </li> <li> <p>results of cognitive functioning measure (neuropsychological test performance);</p> </li> <li> <p>results of other outcome measures (including self‐reported cognitive questionnaires on cognitive symptoms, quality of life, depression, fatigue and adverse events); </p> </li> <li> <p>risk(s) of bias.</p> </li> </ul> </p> <p>Where possible, all data extracted were those relevant to an intention‐to‐treat (ITT) analysis, in which participants are analysed in the groups to which they are assigned. </p> </section> <section id="CD011335-sec-0040"> <h5 class="title">Data management</h5> <p>We used Review Manager 5.4 to collate data (<a href="./references#CD011335-bbs2-0104" title="Review Manager (RevMan). Version 5.4. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2020.">RevMan 2020</a>). For continuous outcomes (e.g. cognitive performance and quality of life measures), we extracted the final values and standard deviations (SDs) and the number of patients assessed at endpoint for each treatment arm to estimate the mean difference (MD) between treatment arms and its standard error (SE). We noted and reviewed the time points for outcome assessment. Where participant and study details were missing, we noted these as a potential limitation of the study. </p> </section> </section> <section id="CD011335-sec-0041"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We used the <i>Cochrane Handbook for Systematic Reviews of Interventions r</i>isk of bias tool to assess the risk of bias in included studies (<a href="./references#CD011335-bbs2-0076" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>), including the assessment of: </p> <p> <ul id="CD011335-list-0008"> <li> <p>selection bias: random sequence generation and allocation concealment;</p> </li> <li> <p>performance bias: blinding of participants, personnel (patients and treatment providers) and outcome assessors; </p> </li> <li> <p>attrition bias: incomplete outcome data;</p> </li> <li> <p>reporting bias: selective reporting of outcomes;</p> </li> <li> <p>other possible sources of bias.</p> </li> </ul> </p> <p>A full risk of bias item list with specific criteria for each item can be found in <a href="./appendices#CD011335-sec-0113">Appendix 5</a>. </p> <p>We interpreted and reported all bias criteria as having a low, high or unclear risk of bias. We reported an unclear risk of bias when insufficient information was provided, or when uncertainty over the potential for bias was present. Two review authors (MK, JD) applied the risk of bias tool independently and resolved differences by discussion. We summarised results in a risk of bias graph and risk of bias summary and interpreted the results with respect to risk of bias. </p> </section> <section id="CD011335-sec-0042"> <h4 class="title">Measures of treatment effect</h4> <p>For continuous outcomes, we used the between‐group mean difference (MD) with 95% confidence interval (CI). We planned to use the standardised mean difference (SMD) with 95% CIs to combine trials that measured the same outcome, but used different methods. For dichotomous outcomes we used the risk ratio (RR) with 95% CI. </p> </section> <section id="CD011335-sec-0043"> <h4 class="title">Unit of analysis issues</h4> <p>We did not identify any study designs with unit‐of‐analysis issues.</p> </section> <section id="CD011335-sec-0044"> <h4 class="title">Dealing with missing data</h4> <p>We did not impute missing outcome data for any outcomes.<br/>  </p> </section> <section id="CD011335-sec-0045"> <h4 class="title">Assessment of heterogeneity</h4> <p>If a meta‐analysis had been possible, we aimed to assess heterogeneity between studies by a formal statistical test to indicate the significance of the heterogeneity (<a href="./references#CD011335-bbs2-0056" title="DeeksJJ . Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ2001;323(7305):157-62. [DOI: 10.1136/bmj.323.7305.157]">Deeks 2001</a>). We planned to Investigate and report heterogeneity according to the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011335-bbs2-0076" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>), and via visual inspection of forest plots. </p> </section> <section id="CD011335-sec-0046"> <h4 class="title">Assessment of reporting biases</h4> <p>Two review authors (MK, JD) reviewed and recorded any details of reporting bias. We aimed to examine funnel plots, if a meta‐analysis that included more than 10 trials was possible, to assess potential small‐study effects, such as publication bias.<br/>  </p> </section> <section id="CD011335-sec-0047"> <h4 class="title">Data synthesis</h4> <p>If sufficient clinically similar trials had been available, we intended to combine data for meta‐analysis using the Cochrane Review Manager software 5.4 (<a href="./references#CD011335-bbs2-0104" title="Review Manager (RevMan). Version 5.4. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2020.">RevMan 2020</a>), as follows: </p> <p> <ul id="CD011335-list-0009"> <li> <p>for continuous outcomes, we planned to pool MDs between treatment arms at the end of follow‐up if trials measured the outcome on the same scale and at the same primary study endpoint, otherwise we planned to pool SMDs; </p> </li> <li> <p>we intended to use random‐effects models for all meta‐analyses, with 95% CIs (<a href="./references#CD011335-bbs2-0057" title="DerSimonianR , LairdN . Meta-analysis in clinical trials. Controlled Clinical Trials1986;7(3):177-88.">DerSimonian 1986</a>); </p> </li> <li> <p>for dichotomous data, we planned to pool RRs (<a href="./references#CD011335-bbs2-0104" title="Review Manager (RevMan). Version 5.4. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2020.">RevMan 2020</a>). </p> </li> </ul> </p> </section> <section id="CD011335-sec-0048"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If sufficient data had been available, we would have reviewed studies separately using the following categories: </p> <p> <ul id="CD011335-list-0010"> <li> <p>drug dose;</p> </li> <li> <p>World Health Organization (WHO) tumour grade (low‐grade/high‐grade).</p> </li> </ul> </p> </section> <section id="CD011335-sec-0049"> <h4 class="title">Sensitivity analysis</h4> <p>If sufficient data had been available, we would have considered the following factors:</p> <p> <ul id="CD011335-list-0011"> <li> <p>differing risk of bias profiles;</p> </li> <li> <p>different classes of agents, doses or scheduling differences.</p> </li> </ul> </p> <p>We anticipated that additional types of sensitivity analyses would have been identified during the conduct of the review. </p> </section> <section id="CD011335-sec-0050"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>Summary of findings tables were created where appropriate and adequate data were provided in relation to the topic of this review. If sufficient data had been available, we would have used the GRADE approach to assess certainty of the body of evidence. <a href="#CD011335-tbl-0001">Table 1</a>; <a href="#CD011335-tbl-0002">Table 2</a>. </p> <div class="table" id="CD011335-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of findings: Memantine versus placebo</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Cognitive functioning measure</b> </p> <p><b>(standardised scores)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Memantine</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p> </p> <p>P</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>N</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median change after 24 weeks (IQR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>N</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median change after 24 weeks (IQR)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short‐term verbal memory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.23 (‐1.16 to 0.70)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.415 (‐1.86 to 0.46)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long‐term verbal memory (recall)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 (‐1.67 to 0.59)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.90 (‐2.22 to 0.55)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.06</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long‐term verbal memory (recognition)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 (‐1.12 to 1.43)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.72 (‐2.73 to 0.71)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.01*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Verbal Fluency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.10 (‐0.62 to 0.53)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.16 (‐0.83 to 0.61)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.31</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trail Making Test A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.08 (‐1.01 to 1.82)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.37 (‐2.08 to 0.50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.02*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trail Making Test B</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.45 (‐2.37 to 1.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.49 (‐2.60 to 0.62)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cognitive composite score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.03 (‐0.90 to 0.72)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.41 (‐1.30 to 0.12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.02*</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>* P &lt; 0.05</p> <p>IQR: interquartile range<br/>  </p> </div> </div> <div class="table" id="CD011335-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Summary of findings: Goal Management Training versus Brain Health Program versus wait‐listed control</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Cognitive performance measure</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Goal Management Training</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Brain Health Program</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Wait‐listed control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Goal Management Training</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Brain Health Program</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Wait‐listed control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>N</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Domain composite score change post‐training compared to baseline (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>N</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Domain composite score change post‐training compared to baseline (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>N</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Domain composite score change post‐training compared to baseline (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>N</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Domain composite score change at 4‐month follow‐up compared to baseline (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>N</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Domain composite score change at 4‐month follow‐up compared to baseline (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>N</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Domain composite score change at 4‐month follow‐up compared to baseline (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Executive composite</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.54)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.08 (0.43)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.44 (0.45)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.077</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.69 (0.51)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.13 (0.50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.07 (0.44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.046</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Memory composite</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.40 (0.84)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.11 (0.91)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.43 (0.76)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.778</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.08 (0.82)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.86 (1.01)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.84 (0.52)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.842</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Processing speed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.44 (0.55)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.47 (0.43)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.65 (1.53)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.071</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.54 (0.57)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.14 (0.94)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.18 (1.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.179</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>SD: standard deviation</p> <p>P values refer to time‐by‐group interaction (intervention) effects on change compared to baseline, using analysis of variance </p> </div> </div> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011335-sec-0051" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011335-sec-0051"></div> <section id="CD011335-sec-0052"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD011335-sec-0131" title="">Characteristics of included studies</a>; <a href="./references#CD011335-sec-0132" title="">Characteristics of excluded studies</a>; <a href="./references#CD011335-sec-0133" title="">Characteristics of studies awaiting classification</a>; <a href="./references#CD011335-sec-0134" title="">Characteristics of ongoing studies</a> </p> <section id="CD011335-sec-0053"> <h4 class="title">Results of the search</h4> <p>Details can be found in <a href="#CD011335-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD011335-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="original image" data-id="CD011335-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> <p>In the original review, six studies were identified for inclusion. Four published trials met our inclusion criteria for analysis; two trials investigating the prevention of cognitive deficits and two trials investigating the amelioration of cognitive deficits. Three conference abstracts were also identified; data were available for one study (<a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a>) and, following correspondence, data were obtained for another study (<a href="./references#CD011335-bbs2-0101" title="RappSR , CaseD , PeifferA , NaughtonMJ , StieberVW , BayerGK , et al. Phase III randomized, double‐blind, placebo‐controlled trial of donepezil in irradiated brain tumor survivors. In: Journal of Clinical Oncology. Vol. 31. 2013:2006.">Rapp 2013</a>). In addition, we identified one study when searching clinical trial databases for ongoing trials (<a href="./references#CD011335-bbs2-0118" title="UmphreyAB . Armodafinil in reducing cancer-related fatigue in patients with high grade glioma.. ClinicalTrials.gov2013. [NCT01781468]">Umphrey 2013</a>). A further study was identified as awaiting classification (<a href="./references#CD011335-bbs2-0107" title="ShawEG , CaseD , BryantD , GrisellD , LesserG , MonittoDC , et al. Phase II double‐blind placebo‐controlled study of armodafinil for brain radiation induced fatigue. In: Journal of Clinical Oncology. Vol. 13. 2013:9505.">Shaw 2013</a>). </p> <p>In the updated search, an additional 1778 citations were identified through database searching, which left 985 records for screening following de‐duplication of the results. Upon screening of titles, this narrowed the results to 21 articles. Of these 21 articles, the updated search identified two new additional studies for inclusion (<a href="./references#CD011335-bbs2-0007" title="RichardNM , BernsteinLJ , MasonWP , LaperriereN , MauriceC , MillarBA , et al. Cognitive rehabilitation for executive dysfunction in brain tumor patients: a pilot randomized controlled trial. Journal of Neuro oncology2019;142(3):565-75. [DOI: 10.1007/s11060-019-03130-1]">Richard 2019</a>; <a href="./references#CD011335-bbs2-0008" title="VossM , WengerKJ , vonMettenheimN , BojungaJ , VetterM , DiehlB , et al. Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial. European Journal of Nutrition2022;61(1):477-87. [DOI: 10.1007/s00394-021-02666-1]">Voss 2022</a>). In addition, the full‐text article (<a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a>) for a conference abstract included in the original review (<a href="./references#CD011335-bbs2-0101" title="RappSR , CaseD , PeifferA , NaughtonMJ , StieberVW , BayerGK , et al. Phase III randomized, double‐blind, placebo‐controlled trial of donepezil in irradiated brain tumor survivors. In: Journal of Clinical Oncology. Vol. 31. 2013:2006.">Rapp 2013</a>) was identified. The full‐text article of the study identified in the original review was awaiting classification (<a href="./references#CD011335-bbs2-0107" title="ShawEG , CaseD , BryantD , GrisellD , LesserG , MonittoDC , et al. Phase II double‐blind placebo‐controlled study of armodafinil for brain radiation induced fatigue. In: Journal of Clinical Oncology. Vol. 13. 2013:9505.">Shaw 2013</a>) was also identified (<a href="./references#CD011335-bbs2-0028" title="PageBR , ShawEG , LuL , BryantD , GrisellD , LesserGJ , et al. Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue. Neuro-oncology2015;17(10):1393-401. ">Page 2015</a>), which did not meet the criteria for inclusion in the review. In addition, the full‐text article of a study identified in the original review as an ongoing trial (<a href="./references#CD011335-bbs2-0118" title="UmphreyAB . Armodafinil in reducing cancer-related fatigue in patients with high grade glioma.. ClinicalTrials.gov2013. [NCT01781468]">Umphrey 2013</a>) was identified (<a href="./references#CD011335-bbs2-0030" title="PorterAB , LiuH , KohliS , CerhanJL , SloanJ , McMurrayRP , et al. Efficacy of treatment with armodafinil for cancer-related fatigue in patients with high-grade glioma: a phase 3 randomized clinical trial. JAMA Oncology2022;8(2):259-67. [DOI: 10.1001/jamaoncol.2021.5948]">Porter 2022</a>), which also did not meet the criteria for inclusion in the review. An ongoing study was identified when searching clinical trial databases for ongoing trials (<a href="./references#CD011335-bbs2-0038" title="ChanMD . Testing ramipril to prevent memory loss in People with glioblastoma. ClinicalTrials.gov2018. [NCT03475186]">Chan 2018</a>). </p> </section> <section id="CD011335-sec-0054"> <h4 class="title">Included studies</h4> <p>For detailed information on included studies see the '<a href="./references#CD011335-sec-0131" title="">Characteristics of included studies</a>' table. </p> </section> <section id="CD011335-sec-0055"> <h4 class="title">Prevention</h4> <p>Two included studies investigated a pharmacological intervention (d‐threo‐methylphenidate hydrochloride and memantine) for the prevention of cognitive deficits during cranial irradiation (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>; <a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>). One included study investigated a cognitive rehabilitation and problem‐solving program for the prevention of cognitive deficits in patients with primary brain tumours receiving radiotherapy (<a href="./references#CD011335-bbs2-0005" title="LockeDEC , CerhanJH , WuW , MalecJF , ClarkMM , Rummans TA, et al. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumours: a pilot study. Journal of Supportive Oncology2008;6(8):383-91. ">Locke 2008</a>). Another study investigated the effect of a calorie‐restricted ketogenic diet and intermittent fasting on progression‐free survival in patients with glioblastoma, with cognitive outcomes as one of a number of secondary outcomes (<a href="./references#CD011335-bbs2-0008" title="VossM , WengerKJ , vonMettenheimN , BojungaJ , VetterM , DiehlB , et al. Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial. European Journal of Nutrition2022;61(1):477-87. [DOI: 10.1007/s00394-021-02666-1]">Voss 2022</a>). </p> <section id="CD011335-sec-0056"> <h5 class="title">Pharmacological Studies</h5> <section id="CD011335-sec-0057"> <h6 class="title">Memantine versus placebo</h6> <p>One study recruited 554 eligible patients with brain metastases primarily from lung cancer, with breast, colon and other cancers also included; 46 patients did not meet the inclusion criteria, therefore 508 participants were allocated to intervention (<i>N</i> = 256; median age [range], 60 [31‐84] years; M:F, 115:141; 84% white); placebo arm (<i>N</i> = 252; median age [range], 59 [29‐86] years; M:F, 107:145; 83.3% white) (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>). This was greater than the calculated 221 participants required in each arm to reach 80% statistical power, although at eight weeks there were 129 and 139 patients in the intervention and placebo arms, respectively; of the 508 eligible patients, 55 withdrew consent and 271 died prior to completion of the study. Overall, 31% and 33% of participants completed 24 weeks of drug use as per the study protocol in the memantine and control groups, respectively. Imputation was carried out for participants still alive at the time of missed assessment. Wilcoxon rank‐sum test, Gray’s Test, Cox proportional hazards regression model, stratified log‐rank test statistical analyses were performed.  </p> </section> <section id="CD011335-sec-0058"> <h6 class="title">d‐threo‐methylphenidate hydrochloride versus placebo</h6> <p>One study recruited 68 patients (intervention arm <i>N</i> = 34; median age [range], 52 [31‐79] years; M:F, 20:14; 76% white; placebo arm <i>N</i> = 34; median age [range], 60 [28‐83] years; M:F, 17:17; 91% white) of the 81 projected patients, calculated for a 90% statistical power, but with much fewer patients for analysis over time. Patients had a primary (<i>N</i> = 33) or metastatic brain tumour (<a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>); further details concerning the brain tumours were not reported. Two participants withdrew consent prior to receiving the intervention, 11 participants withdrew consent following the baseline assessment, 12 following radiation, and 11 after four weeks. Participant withdrawal of consent after eight weeks was not reported. This study was terminated early due to low accrual. Two sample t‐tests, analysis of covariance, mixed‐model analysis of covariance and autoregressive covariance structure statistical analyses were performed.  </p> </section> <section id="CD011335-sec-0059"> <h6 class="title">Comparisons between the pharmacological prevention studies</h6> <p>Both pharmacological prevention studies recruited participants in the USA, and both of these USA studies were multi‐centre studies involving four centres (<a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>), and 143 centres, including Canada (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>). Both studies reported obtaining ethical approval and informed consent from participants, and described the recording of adverse events. Cranial irradiation schedule requirements varied between the two studies, with patients receiving 37.5 Gy of WBRT via 15 fractions of 2.5 Gy (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>) or partial or WBRT of at least 25 Gy in at least 10 fractions of 1.8 to 3.0 Gy/fraction (<a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>). Both studies reported using a randomisation method, which was confirmed via correspondence as random number generation using a computer program, and compared the interventions with a matched placebo group (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>; <a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>). In addition, both studies reported the use of a double‐blinding and allocation concealment technique, which was confirmed via correspondence to have been through the use of a pharmaceutical company providing matched drug containers (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>; <a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>). </p> <p>Interventions included d‐threo‐methylphenidate hydrochloride (d‐MPH; <a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>) and memantine (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>). One study commenced administration of the study drug no later than three days after commencing radiotherapy (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>), and the other within five days of commencing radiotherapy (<a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>). Both pharmacological prevention studies included dose‐escalation techniques, continued for eight (<a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>) or 24 (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>) weeks. Dose reduction and withdrawal techniques were included if patients experienced severe adverse events (<a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>), or when the patient's creatine clearance levels declined (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>). </p> <p>Both studies assessed cognitive functioning using the Mini‐Mental State Examination (MMSE). One study included a neuropsychological test battery that assessed memory, processing speed, executive function and verbal fluency (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>). The other study also included self‐report measures of fatigue, depression and quality of life (<a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>). Timing of cognitive outcome assessment varied between studies, with patients assessed at baseline and then at eight, 16 and 24 weeks of drug use (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>), or at the end of radiation therapy and at eight weeks of drug use (<a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>). Both studies carried out a final follow‐up assessment after the drug was stopped, at 12 (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>) and 52 (<a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>) weeks. </p> </section> </section> <section id="CD011335-sec-0060"> <h5 class="title">Non‐Pharmacological Studies</h5> <section id="CD011335-sec-0061"> <h6 class="title">Cognitive rehabilitation versus standard care</h6> <p><a href="./references#CD011335-bbs2-0005" title="LockeDEC , CerhanJH , WuW , MalecJF , ClarkMM , Rummans TA, et al. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumours: a pilot study. Journal of Supportive Oncology2008;6(8):383-91. ">Locke 2008</a> recruited 19 participants (intervention arm <i>N</i> = 12; median age [range], 47 [30 to 78] years; M:F, 7:5; ethnicity not reported; control arm <i>N</i> = 7; median age [range], 60 [31 to 71] years; M:F, 4:3) receiving cranial irradiation for the treatment of a primary brain tumour (17 glioma, two meningioma), with complete data in 14 of these participants. Six participants withdrew consent prior to completion of the study due to time commitments, tumour progression, fatigue and the unwillingness of a caregiver to attend appointments. Results were reported for 13 participants and their caregivers at post‐intervention and three months follow‐up. Recruitment was carried out at a single radiation oncology clinic. Ethical approval was obtained and informed consent sought. Patients were required to have a caregiver available to accompany them to each follow‐up to complete a quality‐of‐life questionnaire. Radiation schedule requirements were not reported. The use of a randomisation method was reported, however this was abandoned due to low accrual and the final three participants were enrolled into the intervention arm. Due to the nature of the study, participants were not blinded. Blinding of personnel was not reported. </p> <p>The intervention included six 50‐minute sessions of cognitive rehabilitation and six 50‐minute sessions of problem‐solving therapy over two weeks, compared with standard medical care. The cognitive rehabilitation intervention was particularly aimed at memory. This involved the education and use of a calendar to compensate for cognitive problems. The problem‐solving intervention involved the education and training of a positive problem‐solving model via constructive thinking, using feelings as cues and reversed advocacy role play. </p> <p>The primary aim of the study was to assess the tolerability and feasibility of the program. This was assessed through the use of the Mayo‐Portland Adaptability Inventory (<a href="./references#CD011335-bbs2-0086" title="MalecJF , KragnessM , EvansRW , FinlayKL , KentA , LezakM . Further psychometric evaluation and revision of the Mayo-Portland Adaptability Inventory in a national sample. Journal of Head Trauma Rehabilitation2003;18(6):479-92.">Malec 2003</a>), primarily used in the evaluation of rehabilitation programmes designed for patients with acquired brain injury, and via patient feedback questionnaires. Cognitive functioning was assessed using the cognitive test battery Repeatable Battery for the Assessment of Neuropsychological Status (RBANS; <a href="./references#CD011335-bbs2-0100" title="RandolphC . Repeatable battery for the assessment of neuropsychological status (RBANS). Psychological Corporation, San Antonio1998.">Randolph 1998</a>). Self‐reported quality of life, mood and fatigue were also assessed. Assessments were taken at baseline, following the two‐week intervention, and at three months. RBANS was only reported at baseline and post‐intervention as the majority of participants choosing a telephone follow‐up for their final clinic appointment, and consequently cognitive assessment could not be carried out. Wilcoxon signed rank statistical tests were used to assess functional status only. Means and standard deviations for the RBANS subtest were reported for baseline and post‐intervention; mean change and standard deviation of mean change were not reported. </p> </section> <section id="CD011335-sec-0062"> <h6 class="title">Calorie‐restricted ketogenic diet with intermittent fasting versus standard diet</h6> <p><a href="./references#CD011335-bbs2-0008" title="VossM , WengerKJ , vonMettenheimN , BojungaJ , VetterM , DiehlB , et al. Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial. European Journal of Nutrition2022;61(1):477-87. [DOI: 10.1007/s00394-021-02666-1]">Voss 2022</a> recruited 50 patients (intervention arm <i>N</i> = 25; median age [range], 56 [39 to 71] years; gender and ethnicity not reported; control arm <i>N</i> = 25; median age [range], 58 [26 to 75] years) with recurrent glioblastoma receiving re‐irradiation from three German university hospitals. This was greater than the 42 patients necessary to have 80% statistical power. Ethical approval was obtained and informed consent provided by all participants. The radiotherapy regimen proposed by the study authors was 5 x 4 Gy from days four to eight in both groups, but other regimens were allowed. Randomisation, completed using computer software that generated random numbers, and allocation concealment were confirmed by correspondence with the study authors. Blinding of the participants and personnel were not possible due to the nature of the intervention. </p> <p>The intervention comprised of three days of ketogenic diet (21–23 kcal per kg of body weight per day, with carbohydrate intake limited to 50 g per day), followed by three days of fasting and then another three days of ketogenic diet. During the fasting period, patients had an unlimited intake of fluid. From day 10 onwards, no dietary restrictions were implemented. The control group comprised a 'standard diet', with nutritional counselling in line with German Society of Nutrition guidelines, recommending a calorie intake of approximately 30 kcal per kg of body weight per day. Four participants (two from each group) withdrew consent to take part in the trial before the diet, and a further four participants stopped the diet during treatment (three from the intervention group and one from the standard diet group). There were 20 participants in the intervention group and 22 participants in the standard diet group who completed the evaluation as set by the protocol. Cognitive functioning was assessed as a secondary outcome using the MMSE and the d2 Test of Attention at baseline, day 6, day 12 and one month after radiotherapy. Of these, data on results of the d2 Test of Attention were available for 29 participants at baseline, 27 participants at day 6, 28 participants at day 12, and 27 participants at one month. The number of participants with data available for the MMSE were not specified.  </p> <p>The primary endpoint of the study was progression‐free survival at six months, and secondary endpoints included: progression‐free survival; local progression‐free survival at six weeks, three months and 12 months; overall survival; frequency of epileptic seizures; extent of ketosis; quality of life; and cognitive function. Dependent and independent samples <i>t</i> tests, Wilcoxon tests, chi‐squared tests, Kaplan‐Meier survival analysis and log‐rank tests were performed.  </p> </section> </section> </section> <section id="CD011335-sec-0063"> <h4 class="title">Amelioration</h4> <p>Three pharmacological studies (<a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>; <a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a>; <a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a>) and one non‐pharmacological study (<a href="./references#CD011335-bbs2-0007" title="RichardNM , BernsteinLJ , MasonWP , LaperriereN , MauriceC , MillarBA , et al. Cognitive rehabilitation for executive dysfunction in brain tumor patients: a pilot randomized controlled trial. Journal of Neuro oncology2019;142(3):565-75. [DOI: 10.1007/s11060-019-03130-1]">Richard 2019</a>) were included that investigated the treatment of cognitive deficits. </p> <section id="CD011335-sec-0064"> <h5 class="title">Pharmacological Studies</h5> <section id="CD011335-sec-0065"> <h6 class="title">Modafinil at two different doses</h6> <p>One study recruited 30 of 30 expected patients (mean age [standard deviation], 45.3 [11.7] years; M:F, 19:11, ethnicity not reported) with a primary brain tumour, 87% of whom had received radiotherapy (<a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a>); the distribution of tumour grade was almost equal between grade II, III and IV tumours, with two patients with a grade I tumour. Results were reported for all participants at baseline, and at eight and 12 weeks of drug use. Groups were combined for statistical analysis, and paired t‐tests and Wilcoxon Signed Rank tests were used to assess change from baseline.  </p> </section> <section id="CD011335-sec-0066"> <h6 class="title">Methylphenidate versus modafinil</h6> <p>Another study recruited 34 of the 75 planned patients with a primary brain tumour, calculated to have 90% statistical power. Four participants were excluded from the study; three due to tumour progression (two methylphenidate arm; one modafinil arm), and one due to infection‐related delirium requiring hospitalisation (modafinil arm). A further six participants dropped out; three due to the prescription not being filled (two methylphenidate arm; one modafinil arm), one due to nausea (modafinil arm), one due to steroid‐induced hyperactivity (modafinil arm), and one missed the follow‐up appointment (methylphenidate arm). Results were reported for 24 participants at four weeks of treatment (21 glioma, one medulloblastoma, one primary central nervous system (CNS) lymphoma, one hemangiopericytoma; methylphenidate arm <i>N</i> = 19; mean age [standard deviation], 42.5 [10.2] years; M:F, 8:11; ethnicity not reported; modafinil arm <i>N</i> = 5; mean age [standard deviation], 54.4 [7.7] years; M:F, 5:0); 83% of whom had received cranial irradiation prior to participation and 62.5% were receiving chemotherapy during participation (<a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>).  Despite randomisation, there were significantly more males in the modafinil group, compared to the methylphenidate group (P = 0.03). An exploratory statistical analysis approach was used via t‐tests and repeated measures analyses of covariance. Due to low accrual, the two methylphenidate arms were combined during analysis; further analysis also combined all interventions and compared findings with normative data. Practice effect adjusted reliable change index was used to assess individual change in cognitive test scores relative to baseline.  </p> </section> <section id="CD011335-sec-0067"> <h6 class="title">Donepezil versus placebo</h6> <p>A further study recruited 198 of the required 200 patients (intervention arm <i>N</i> = 99; median age [range], 56 [19‐84] years; M:F, 43:56; 91% white; control arm <i>N</i> = 99; median age [range], 54 [19‐81] years; M:F, 49:50; 91% white), required to reach 90% statistical power, from 26 sites; 130 had a primary brain tumour, 53 a metastatic brain tumour, and 15 had received prophylactic cranial irradiation (<a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a>). Fifty‐two participants dropped out of the study; reasons were not reported. Results were presented for 146 participants at 24 weeks follow‐up. Chi<sup>2</sup>, Fisher exact and Wilcoxon rank‐sum statistical tests were used. Imputation was carried out in all participants who provided at least baseline data. </p> </section> <section id="CD011335-sec-0068"> <h6 class="title">Comparisons between the pharmacological amelioration studies</h6> <p>Two studies initially reported their results as a conference abstract (<a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a>; <a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a>), with data from only one of these appearing in a full manuscript at the time this review was conducted (<a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a>). All three studies were conducted in the USA. Ethical approval and informed consent was reported for two studies (<a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>; <a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a>) and all reported adverse events. Two studies did not restrict patients to those receiving cranial irradiation (<a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>; <a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a>). In one study, patients were eligible to participate following partial or whole brain irradiation of 30 Gy or greater (<a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a>). The use of a randomisation method was reported by all studies, and correspondence confirmed this and was through the use of a computer program in two studies (<a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>; <a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a>). Two studies used double‐blinding (<a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a>; <a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a>), and one study also reported an allocation concealment method via a pharmaceutical company (<a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a>). One study used an open‐label design, although all treatment arms were experimental (<a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>). </p> <p>Intervention arms varied between studies. <a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a> compared two dosages of modafinil followed by an extended treatment phase using a titrated dose between 50 mg and 600 mg/day for eight weeks. <a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a> included three intervention arms using two forms of methylphenidate (immediate release and sustained release, combined for analysis), compared to a modafinil arm. <a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a> included one intervention arm of donepezil, with an increasing dosage from 5 mg/day for six weeks and 10 mg/day for 18weeks if tolerated, compared with placebo.  </p> <p>All studies assessed cognitive functioning using neuropsychological testing, and one also calculated a cognitive composite score (<a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a>). All studies included self‐reported measures of mood and fatigue, and one also included a measure of quality of life (<a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>). Assessments were taken at baseline and at four weeks of drug use (<a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>), at baseline, 12 and 24 weeks of drug use (<a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a>), or at baseline and at one, three, four, eight and 12 weeks of drug use (<a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a>). <a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a> used alternate test forms when possible and statistical corrections to minimise re‐test effects. Assessments were not carried out following withdrawal of the drug, but were recorded in one study during a washout period prior to the extension phase (<a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a>). </p> </section> </section> <section id="CD011335-sec-0069"> <h5 class="title">Non‐Pharmacological Studies</h5> <section id="CD011335-sec-0070"> <h6 class="title">Goal Management Training versus active control and wait‐list control</h6> <p><a href="./references#CD011335-bbs2-0007" title="RichardNM , BernsteinLJ , MasonWP , LaperriereN , MauriceC , MillarBA , et al. Cognitive rehabilitation for executive dysfunction in brain tumor patients: a pilot randomized controlled trial. Journal of Neuro oncology2019;142(3):565-75. [DOI: 10.1007/s11060-019-03130-1]">Richard 2019</a> recruited 26 patients with meningioma, low‐grade glioma or high‐grade glioma, one of whom experienced disease progression before baseline testing and was thus excluded, leaving 25 patients (demographic data not reported by group allocation; overall median age [range], 48 [21‐68] years; M:F, 15:10; ethnicity not reported) for analysis (20 for post‐intervention analysis). No formal power calculation was described for this study. The study was conducted in Canada. Ethical approval and informed consent was reported. The study did not restrict inclusion to those receiving cranial irradiation (85% received cranial irradiation). Patients were randomised using a random number generator and allocation concealment was achieved through the allocation spreadsheet being viewable only to the intervention provider, confirmed by correspondence with the study authors. Blinding of participants was not possible due to the nature of the interventions. </p> <p>There were three groups in this study. The intervention comprised of Goal Management Training, a behavioural intervention that combined mindfulness and strategy training, delivered in eight two‐hour individual sessions by a clinical neuropsychologist. An active control group underwent a novel psycho‐educational Brain Health Program that included content on brain and cognition but no cognitive strategy training, also delivered in eight two‐hour individual sessions by a clinical neuropsychologist. The third group was a wait‐list passive control group that received usual care but no neuropsychological intervention. In the Goal Management Training group, one participant only completed six out of eight sessions (due to new employment). In the active control group, one participant withdrew after baseline assessments without providing a reason, and another after completing seven out of eight sessions (due to increased work responsibilities). In the wait‐list control group, one participant withdrew after baseline assessment with no reason provided, one declined assessment at post‐training, and an additional two declined at follow‐up (all citing a lack of time). An analysis comparing study completers (n = 21) and non‐completers (n = 4) showed that non‐completers were younger at enrolment and had worse language abilities, slower processing speed, and higher apathy scores.  </p> <p>Following randomisation, 11, eight and six participants were allocated to the Goal Management Training, active control and wait‐list control groups, respectively, with data on 10, six, and four available for post‐intervention analyses. Cognitive function was assessed using neuropsychological testing covering the domains of executive functioning, memory, and processing speed. The study also assessed self‐reported measures of cognitive symptoms, emotional functioning, coping and adjustment and everyday life function. Assessments were completed at baseline, immediately following the training and at four months. Analysis of variance, Pearson's Chi<sup>2</sup>, Kruskal‐Wallis and Mann‐Whitney U statistical tests were performed. The primary outcome measure was change in the executive functioning composite score. Secondary endpoints included changes in processing speed, memory, self‐reported cognitive symptoms, emotional functioning and coping/adjustment, programme adherence and patient‐reported use and effects of programme contents, including functional goal attainment. </p> </section> </section> </section> <section id="CD011335-sec-0071"> <h4 class="title">Excluded studies</h4> <p>For detailed information on excluded studies see the '<a href="./references#CD011335-sec-0132" title="">Characteristics of excluded studies</a>' table. </p> <p>In the original review, after screening 16 full‐text articles, 10 studies were excluded in the original review (<a href="./references#CD011335-bbs2-0009" title="AttiaA , RappSR , CaseLD , D'AgostinoR , LesserG , NaughtonM , et al. Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood. Journal of Neuro-oncology2012;109:357-63. [DOI: 10.1007/s11060-012-0901-9]">Attia 2012</a>; <a href="./references#CD011335-bbs2-0011" title="BoeleFW , DouwL , deGrootM , Van ThuijlHF , CleijneW , HeimansJJ , et al. The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: a multicenter randomized controlled trial. Neuro-oncology2013;15(10):1420-8. [DOI: 10.1093/neuonc/not102]">Boele 2013</a>; <a href="./references#CD011335-bbs2-0014" title="ChanAS , CheungMC , LawSC , ChanJH . Phase II study of alpha-tocopherol in improving the cognitive function of patients with temporal lobe radionecrosis. Cancer2004;100(2):398-404. [DOI: 10.1002/cncr.11885]">Chan 2003</a>; <a href="./references#CD011335-bbs2-0016" title="GehringK , SitskoornMM , GundyCM , SikkesSA , KleinM , PostmaTJ , et al. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. Journal of Clinical Oncology2009;27(22):3712-22. [DOI: 10.1200/JCO.2008.20.5765]">Gehring 2009</a>; <a href="./references#CD011335-bbs2-0019" title="HulshofMCC , StarkNM , van derKleijA , SminiaP , SmedingHM , GonzalezDG . Hyperbaric oxygen therapy for cognitive disorders after irradiation of the brain [Hyperbare oxygenierung bei patienten mit kognitiven störungen nach hirnbestrahlung]. Strahlentherapie und Onkologie2002;178(4):192-8. [DOI: 10.1007/s00066-002-0916-9]">Hulshof 2002</a>; <a href="./references#CD011335-bbs2-0020" title="JatoiA , KahanicSP , FrytakS , SchaeferP , FooteRL , SloanJ , et al. Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs. Supportive Care in Cancer2005;13:66-9. [DOI: 10.1007/s00520-004-0696-0]">Jatoi 2005</a>; <a href="./references#CD011335-bbs2-0022" title="LevinVA , BidautL , HouP , KumarAJ , WefelJS , BekeleBN , et al. Randomized double‐blind placebo‐controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. International Journal of Radiation Oncology *Biology *Physics2011;79(5):1487-95. ">Levin 2011</a>; <a href="./references#CD011335-bbs2-0024" title="MeyersCA , WeitznerMA , ValentineAD , LevinVA . Methylphenidate therapy improves cognition, mood and function of brain tumor patients. Journal of Clinical Oncology1998;16(7):2522-7. ">Meyers 1998</a>; <a href="./references#CD011335-bbs2-0031" title="SchellartNA , ReitsD , van der Kleij, StalpersLJ . Hyperbaric oxygen treatment improved neurophysiologic performance in brain tumor patients after neurosurgery and radiotherapy: a preliminary report. Cancer2011;117(15):3434-44. [DOI: 10.1002/cncr.25874]">Schellart 2011</a>; <a href="./references#CD011335-bbs2-0032" title="ShawEG , RosdhalR , D'Agostino RB Jr, LovatoJ , NaughtonMJ , RobbinsME , et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. Journal of Clinical Oncology2006;24(9):1415-20. ">Shaw 2006</a>). </p> <p>For this update, 21 full‐text articles were screened, and a further 19 studies were excluded: </p> <p> <ul id="CD011335-list-0012"> <li> <p>Seven amelioration studies investigating lidocaine (<a href="./references#CD011335-bbs2-0029" title="PengY , ZhangW , ZhouX , JiY , KassIS , HanR . Lidocaine did not reduce neuropsychological-cognitive decline in patients 6 months after supratentorial tumor surgery: a randomized, controlled trial. Journal of Neurosurgical Anesthesiology2016;28(1):6-13. ">Peng 2016</a>), Internet‐based guided self‐help (<a href="./references#CD011335-bbs2-0012" title="BoeleFW , KleinM , Verdonck-de LeeuwIM , CuijpersP , HeimansJJ , SnijdersTJ , et al. Internet-based guided self-help for glioma patients with depressive symptoms: a randomized controlled trial. Journal of Neuro-oncology2018;137(1):191-203. ">Boele 2018</a>), cognitive rehabilitation (<a href="./references#CD011335-bbs2-0033" title="van derLindenSD , SitskoornMM , RuttenGM , GehringK . Feasibility of the evidence-based cognitive telerehabilitation program Remind for patients with primary brain tumors. Journal of Neuro-oncology2018;137(3):523-32. ">Van der Linden 2018</a>; <a href="./references#CD011335-bbs2-0034" title="van derLindenSD , RuttenGM , DirvenL , TaphoornMJB , SatoerDD , DirvenCMF , et al. eHealth cognitive rehabilitation for brain tumor patients: results of a randomized controlled trial. Journal of Neuro-oncology2021;154(3):315-26. [DOI: 10.1007/s11060-021-03828-1]">van der Linden 2021</a>), home‐based exercise (<a href="./references#CD011335-bbs2-0017" title="GehringK , KloekCJ , AaronsonNK , JanssenKW , JonesLW , SitskoornMM , et al. Feasibility of a home-based exercise intervention with remote guidance for patients with stable grade II and III gliomas: a pilot randomized controlled trial. Clinical Rehabilitation2018;32(3):352-66. ">Gehring 2018</a>; <a href="./references#CD011335-bbs2-0018" title="GehringK , StuiverMM , VisserE , KloekC , vanden BentM , HanseM , et al. A pilot randomized controlled trial of exercise to improve cognitive performance in patients with stable glioma: a proof of concept. Neuro Oncology2020;22(1):103-15. ">Gehring 2020</a>), and home‐based psychotherapy and rehabilitation (<a href="./references#CD011335-bbs2-0027" title="OwnsworthT , ChambersS , StewartE , CaseyL , WalkerDG , ShumDHK . The making sense of brain tumour project: A homebased psychotherapy and rehabilitation program. Asia-Pacific journal of Clinical Oncology2012;8:184-5. ">Ownsworth 2012</a>) did not include a majority (80%) of participants who had received cranial irradiation, or did not analyse these patients separately. Two of these studies (<a href="./references#CD011335-bbs2-0017" title="GehringK , KloekCJ , AaronsonNK , JanssenKW , JonesLW , SitskoornMM , et al. Feasibility of a home-based exercise intervention with remote guidance for patients with stable grade II and III gliomas: a pilot randomized controlled trial. Clinical Rehabilitation2018;32(3):352-66. ">Gehring 2018</a>; <a href="./references#CD011335-bbs2-0033" title="van derLindenSD , SitskoornMM , RuttenGM , GehringK . Feasibility of the evidence-based cognitive telerehabilitation program Remind for patients with primary brain tumors. Journal of Neuro-oncology2018;137(3):523-32. ">Van der Linden 2018</a>) also did not include cognitive impairment as an inclusion criterion, and one study (<a href="./references#CD011335-bbs2-0012" title="BoeleFW , KleinM , Verdonck-de LeeuwIM , CuijpersP , HeimansJJ , SnijdersTJ , et al. Internet-based guided self-help for glioma patients with depressive symptoms: a randomized controlled trial. Journal of Neuro-oncology2018;137(1):191-203. ">Boele 2018</a>) did not include cognitive assessment via neuropsychological testing. </p> </li> <li> <p>One amelioration study investigating cognitive rehabilitation (<a href="./references#CD011335-bbs2-0023" title="MaschioM , DinapoliL , FabiA , GiannarelliD , CantelmiT . Cognitive rehabilitation training in patients with brain tumor-related epilepsy and cognitive deficits: a pilot study. Journal of Neuro-oncology2015;125(2):419-26. ">Maschio 2015</a>) did not include a control group. </p> </li> <li> <p>Three amelioration studies investigating armodafinil (<a href="./references#CD011335-bbs2-0028" title="PageBR , ShawEG , LuL , BryantD , GrisellD , LesserGJ , et al. Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue. Neuro-oncology2015;17(10):1393-401. ">Page 2015</a>; <a href="./references#CD011335-bbs2-0030" title="PorterAB , LiuH , KohliS , CerhanJL , SloanJ , McMurrayRP , et al. Efficacy of treatment with armodafinil for cancer-related fatigue in patients with high-grade glioma: a phase 3 randomized clinical trial. JAMA Oncology2022;8(2):259-67. [DOI: 10.1001/jamaoncol.2021.5948]">Porter 2022</a>) and dexamphetamine sulfate (<a href="./references#CD011335-bbs2-0021" title="Laigle-DonadeyF , DucrayF , BooneM , DialloH , RamirezC , ChinotO , et al. A phase III double-blind placebo-controlled randomised study of dexamphetamine sulfate for fatigue in patients suffering from primary brain tumors. In: MASCC/ISOO Annual Meeting on Supportive Care in Cancer. 2018. ">Laigle‐donadey 2018</a>) did not include cognitive impairment in at least one domain as an inclusion criterion. </p> </li> <li> <p>One prevention study investigating the radioprotective effect of memantine (<a href="./references#CD011335-bbs2-0035" title="WongP , LeppertIR , RobergeD , BoudamK , BrownPD , MuanzaT , et al. A pilot study using dynamic contrast enhanced-MRI as a response biomarker of the radioprotective effect of memantine in patients receiving whole brain radiotherapy. Oncotarget2016;7(32):50986–96. ">Wong 2016</a>) was a sub‐study of a study already included in the review (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>) </p> </li> <li> <p>One study investigating donepezil (<a href="./references#CD011335-bbs2-0026" title="NaughtonMJ , CaseLD , PeifferA , ChanM , StieberV , MooreD , et al. Quality of life of irradiated brain tumor survivors treated with donepezil or placebo: Results of the WFU CCOP research base protocol 91105. Neuro-oncology Practice2018;5(2):114-21. ">Naughton 2018</a>) did not include cognitive assessment via neuropsychology testing. </p> </li> <li> <p>Two amelioration studies investigating the role of metformin (<a href="./references#CD011335-bbs2-0010" title="AyoubR , RuddyRM , CoxE , OyefiadeA , DerkachD , LaughlinS , et al. Assessment of cognitive and neural recovery in survivors of pediatric brain tumors in a pilot clinical trial using metformin. Nature Medicine2020;26(8):1285-94. [DOI: 10.1038/s41591-020-0985-2]">Ayoub 2020</a>) and aerobic exercise training (<a href="./references#CD011335-bbs2-0015" title="CoxE , BellsS , TimmonsBW , LaughlinS , BouffetE , deMedeirosC , et al. A controlled clinical crossover trial of exercise training to improve cognition and neural communication in pediatric brain tumor survivors. Clinical Neurophysiology2020;131(7):1533-47. [DOI: 10.1016/j.clinph.2020.03.027]">Cox 2020</a>) on cognition focused on childhood cancer survivors that were largely still children at the point of recruitment into the study. </p> </li> <li> <p>One study evaluating the role of exercise therapy focused on postmenopausal breast cancer survivors (<a href="./references#CD011335-bbs2-0013" title="CampbellKL , KamJW , Neil-SztramkoSE , Liu AmbroseT , HandyTC , LimHJ , et al. Effect of aerobic exercise on cancer-associated cognitive impairment: A proof-of-concept RCT. Psychooncology2018;27(1):53-60. [DOI: 10.1002/pon.4370]">Campbell 2017</a>). </p> </li> <li> <p>One study evaluating the role of online couple‐based meditation for patients in primary or metastatic brain tumours did not formally assess cognitive outcomes (<a href="./references#CD011335-bbs2-0025" title="MilburyK , WeathersSP , DurraniS , LiY , WhisenantM , LiJ , et al. Online couple-based meditation intervention for patients with primary or metastatic brain tumors and theirpPartners: results of a pilot randomized controlled trial. Journal of Pain Symptom Management2020;59(6):1260-7. [DOI: 10.1016/j.jpainsymman.2020.02.004]">Milbury 2020</a>). </p> </li> <li> <p>One amelioration study evaluating the role of virtual reality training on cognitive outcomes in brain tumour patients with cognitive dysfunction did not specify how many patients received radiotherapy (<a href="./references#CD011335-bbs2-0036" title="YangS , ChunMH , SonYR . Effect of virtual reality on cognitive dysfunction in patients with brain tumor. Annals of Rehabilitation Medicine2014;38(6):726-33. [DOI: 10.5535/arm.2014.38.6.726]">Yang 2014</a>). </p> </li> <li> <p>One prevention study investigating Shenqi fuzheng (<a href="./references#CD011335-bbs2-0037" title="ChenLJ , ZhangRG , YuDD , WuG , DongXR . Shenqi Fuzhengi Injection ameliorates radiation-induced brainiInjury. Current Medical Science2019;39(6):965-71. [DOI: https://doi.org/10.1007/s11596-019-2129-9]">Chen 2019</a>) was published as a randomised controlled trial although some aspects of the exclusion criteria needed clarification. At the time of publication of this systematic review update no further clarification was available from the authors. As a result, we have placed the study in the 'Studies awaiting Clarification' section. </p> </li> </ul> </p> <section id="CD011335-sec-0072"> <h5 class="title">Studies Awaiting Classification</h5> <p>In the original review there was one study published in conference proceedings (<a href="./references#CD011335-bbs2-0107" title="ShawEG , CaseD , BryantD , GrisellD , LesserG , MonittoDC , et al. Phase II double‐blind placebo‐controlled study of armodafinil for brain radiation induced fatigue. In: Journal of Clinical Oncology. Vol. 13. 2013:9505.">Shaw 2013</a>). The updated search identified the full published article (<a href="./references#CD011335-bbs2-0028" title="PageBR , ShawEG , LuL , BryantD , GrisellD , LesserGJ , et al. Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue. Neuro-oncology2015;17(10):1393-401. ">Page 2015</a>) which did not meet the inclusion criteria to be included in the review as it did not include cognitive impairment in at least one cognitive domain as an inclusion criterion (see '<a href="./references#CD011335-sec-0132" title="">Characteristics of excluded studies</a>' table). In addition, as mentioned above one study (<a href="./references#CD011335-bbs2-0037" title="ChenLJ , ZhangRG , YuDD , WuG , DongXR . Shenqi Fuzhengi Injection ameliorates radiation-induced brainiInjury. Current Medical Science2019;39(6):965-71. [DOI: https://doi.org/10.1007/s11596-019-2129-9]">Chen 2019</a>) was published as a randomised controlled trial although some aspects of the exclusion criteria needed clarification that was not available from the authors at the time of publication of this systematic review update.  </p> </section> <section id="CD011335-sec-0073"> <h5 class="title">Ongoing Studies</h5> <p>In the original review there was one ongoing study identified (<a href="./references#CD011335-bbs2-0118" title="UmphreyAB . Armodafinil in reducing cancer-related fatigue in patients with high grade glioma.. ClinicalTrials.gov2013. [NCT01781468]">Umphrey 2013</a>). The full‐text version of this study has now been published (<a href="./references#CD011335-bbs2-0030" title="PorterAB , LiuH , KohliS , CerhanJL , SloanJ , McMurrayRP , et al. Efficacy of treatment with armodafinil for cancer-related fatigue in patients with high-grade glioma: a phase 3 randomized clinical trial. JAMA Oncology2022;8(2):259-67. [DOI: 10.1001/jamaoncol.2021.5948]">Porter 2022</a>), which was excluded because the study did not meet the criteria to be included in the review as it did not include cognitive impairment in at least one cognitive domain as an inclusion criterion (see <a href="./references#CD011335-sec-0132" title="">Characteristics of excluded studies</a> table). The updated search found one additional ongoing study, evaluating the effect of ramipril on memory loss in patients with glioblastoma receiving chemoradiation (<a href="./references#CD011335-bbs2-0038" title="ChanMD . Testing ramipril to prevent memory loss in People with glioblastoma. ClinicalTrials.gov2018. [NCT03475186]">Chan 2018</a>). </p> </section> </section> </section> <section id="CD011335-sec-0074"> <h3 class="title">Risk of bias in included studies</h3> <p>We assessed studies using the Cochrane risk of bias tool (<a href="./references#CD011335-bbs2-0076" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). Between the two review authors of the original (JD, KZ) and updated (MK, JD) reviews, there was agreement in the risk of bias scores following discussion. Attempts to contact authors were carried out where there was an unclear risk of bias. A summary of the risk of bias is presented in <a href="#CD011335-fig-0002">Figure 2</a> and <a href="#CD011335-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD011335-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011335-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD011335-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011335-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD011335-sec-0075"> <h4 class="title">Allocation</h4> <p>Three of the five pharmacological studies were at a low risk of bias in relation to random sequence generation and allocation concealment as they used a stratification randomisation method and a pharmaceutical company to create identical drug containers (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>; <a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>; <a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a>). One pharmacological study was at an unclear risk of bias in relation to random sequence generation as it reported the use of a randomisation method, however the method used could not be identified (<a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a>). The same study had a low risk of bias in relation to allocation concealment as blinding was used (<a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a>). Two studies were at a high risk of bias regarding allocation concealment: one of these was a pharmacological study that used an open‐label design (<a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>); the other was a non‐pharmacological study that reported the use of a randomisation method but this was abandoned due to low accrual, which also placed it at a high risk of bias in relation to random sequence generation (<a href="./references#CD011335-bbs2-0005" title="LockeDEC , CerhanJH , WuW , MalecJF , ClarkMM , Rummans TA, et al. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumours: a pilot study. Journal of Supportive Oncology2008;6(8):383-91. ">Locke 2008</a>). The pharmacological study at a high risk of bias regarding allocation concealment was at a low risk of bias regarding random sequence generation as a computer was used for randomisation (<a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>). Two of the three non‐pharmacological studies had a low risk of bias in relation to random sequence generation and allocation concealment as patients were randomised using a random number generator and allocation concealment was confirmed by correspondence with the authors (<a href="./references#CD011335-bbs2-0007" title="RichardNM , BernsteinLJ , MasonWP , LaperriereN , MauriceC , MillarBA , et al. Cognitive rehabilitation for executive dysfunction in brain tumor patients: a pilot randomized controlled trial. Journal of Neuro oncology2019;142(3):565-75. [DOI: 10.1007/s11060-019-03130-1]">Richard 2019</a>; <a href="./references#CD011335-bbs2-0008" title="VossM , WengerKJ , vonMettenheimN , BojungaJ , VetterM , DiehlB , et al. Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial. European Journal of Nutrition2022;61(1):477-87. [DOI: 10.1007/s00394-021-02666-1]">Voss 2022</a>). </p> </section> <section id="CD011335-sec-0076"> <h4 class="title">Blinding</h4> <p>Four of the five pharmacological studies were at a low risk of bias and blinded participants and personnel to the intervention group (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>; <a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>; <a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a>; <a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a>). The other pharmacological study used an open‐label design (<a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>) and was at a high risk of bias. The three non‐pharmacological studies (<a href="./references#CD011335-bbs2-0005" title="LockeDEC , CerhanJH , WuW , MalecJF , ClarkMM , Rummans TA, et al. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumours: a pilot study. Journal of Supportive Oncology2008;6(8):383-91. ">Locke 2008</a>; <a href="./references#CD011335-bbs2-0007" title="RichardNM , BernsteinLJ , MasonWP , LaperriereN , MauriceC , MillarBA , et al. Cognitive rehabilitation for executive dysfunction in brain tumor patients: a pilot randomized controlled trial. Journal of Neuro oncology2019;142(3):565-75. [DOI: 10.1007/s11060-019-03130-1]">Richard 2019</a>; <a href="./references#CD011335-bbs2-0008" title="VossM , WengerKJ , vonMettenheimN , BojungaJ , VetterM , DiehlB , et al. Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial. European Journal of Nutrition2022;61(1):477-87. [DOI: 10.1007/s00394-021-02666-1]">Voss 2022</a>) were at a high risk of bias; blinding of participants to the intervention was not possible due to the nature of the intervention, and in two of these studies blinding of assessors was also not carried out (<a href="./references#CD011335-bbs2-0005" title="LockeDEC , CerhanJH , WuW , MalecJF , ClarkMM , Rummans TA, et al. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumours: a pilot study. Journal of Supportive Oncology2008;6(8):383-91. ">Locke 2008</a>; <a href="./references#CD011335-bbs2-0008" title="VossM , WengerKJ , vonMettenheimN , BojungaJ , VetterM , DiehlB , et al. Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial. European Journal of Nutrition2022;61(1):477-87. [DOI: 10.1007/s00394-021-02666-1]">Voss 2022</a>). </p> </section> <section id="CD011335-sec-0077"> <h4 class="title">Incomplete outcome data</h4> <p>The majority of studies included reasons for participant dropout, which were unlikely to be related to the outcomes and all studies were judged at a low risk of bias. Three studies performed intention‐to‐treat analyses (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>; <a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>; <a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a>). One study was terminated early (<a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>). Three studies recruited the projected number of participants (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>; <a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a>; <a href="./references#CD011335-bbs2-0008" title="VossM , WengerKJ , vonMettenheimN , BojungaJ , VetterM , DiehlB , et al. Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial. European Journal of Nutrition2022;61(1):477-87. [DOI: 10.1007/s00394-021-02666-1]">Voss 2022</a>). However, no study was able to include the number of participants required to reach the desired statistical power due to withdrawal from participation as a result of patient death, tumour progression or withdrawal of consent. One study reported the use of a multiple imputation procedure via the Markov chain Monte Carlo method for patients still alive at the time of assessments; this included the imputation of scores for 47% of recruited participants at 24 weeks (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>). One study reported the use of an imputation method in all participants (<a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a>). Two studies carried out statistical comparisons between patients who withdrew consent, and those who remained in the study (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>; <a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>). <a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a> reported that patients who dropped out were significantly older and with worse performance status, but did not differ in any of the outcome measures. <a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a> reported that patients who could not complete cognitive assessments were more likely to have worse neurological function and a shorter survival time and had not undergone surgery or radiosurgery. In one study (<a href="./references#CD011335-bbs2-0005" title="LockeDEC , CerhanJH , WuW , MalecJF , ClarkMM , Rummans TA, et al. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumours: a pilot study. Journal of Supportive Oncology2008;6(8):383-91. ">Locke 2008</a>), most patients did not return in‐person for follow‐up, instead electing for telephone follow‐up; as the cognitive test used (RBANS) cannot be administered via telephone, most patients did not complete the RBANS at follow‐up. </p> </section> <section id="CD011335-sec-0078"> <h4 class="title">Selective reporting</h4> <p>All outcomes were reported by all included studies and therefore were all judged at a low risk of bias. It was noted that some studies did not report assessments carried out following withdrawal of the drug (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>; <a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>), and did not report interim assessments (<a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a>; <a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a>). </p> </section> <section id="CD011335-sec-0079"> <h4 class="title">Other potential sources of bias</h4> <p>An unclear risk of bias was reported for three studies. Due to a small sample size, two studies combined intervention groups of participants receiving different forms of the drug methylphenidate (<a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>) and different doses of modafinil (<a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a>) when analysing results. One study did not perform statistical analyses on the cognitive data pre‐/post‐intervention, instead providing only descriptive data (<a href="./references#CD011335-bbs2-0005" title="LockeDEC , CerhanJH , WuW , MalecJF , ClarkMM , Rummans TA, et al. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumours: a pilot study. Journal of Supportive Oncology2008;6(8):383-91. ">Locke 2008</a>). </p> </section> </section> <section id="CD011335-sec-0080"> <h3 class="title" id="CD011335-sec-0080">Effects of interventions</h3> <p>In the original review, study interventions and comparisons were heterogenous, and were too different clinically to be able to pool the data. Following the addition of two additional studies in this updated review, the same issue still prevents pooling of data. Eight studies were identified for inclusion in the review. Due to differences in interventions and aim of interventions (prevention versus amelioration) investigated, including the use of drugs with different modes of actions and dosage schedules, and use of different non‐pharmacological interventions, the results are reviewed separately in this review. </p> <section id="CD011335-sec-0081"> <h4 class="title">Prevention</h4> <section id="CD011335-sec-0082"> <h5 class="title">Pharmacological Studies</h5> <p>The large differences in the mode of action of the drugs investigated, and the unavailability of mean changes in scores, standard deviations or P values, meant pooling of the data was inappropriate. Therefore, results of the studies are reviewed separately and the data are reviewed as reported in the study. </p> <section id="CD011335-sec-0083"> <h6 class="title">Memantine versus placebo</h6> <p><a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a> compared memantine, which acts on the glutamatergic system as an N‐Methyl‐D‐aspartate receptor antagonist, with placebo intervention in patients with brain metastases. Mean cognitive decline was reported for 280 participants at eight, 16 and 24 weeks assessments. The primary endpoint was Hopkins Verbal Learning Test‐Revised (HVLT‐R) at 24 weeks, but between‐group (n = 149) differences in decline did not reach significance (P =0.059); this was attributed to attrition. The memantine arm had significantly longer time to cognitive decline (hazard ratio (HR) 0.78, 95% confidence interval (CI) 0.62‐0.99, P = 0.01), which was a secondary endpoint; the probability of cognitive function failure at 24 weeks was 53.8% in the memantine arm and 64.9% in the placebo arm. Median change and interquartile ranges (IQRs) were also reported for individual neuropsychological tests at 24 weeks, which are summarised in <a href="#CD011335-tbl-0001">Table 1</a>. A cognitive functioning composite score was also calculated and the median change was ‐0.41 (IQR) ‐1.30 to 0.12) in the control group and ‐0.03 (IQR ‐0.90 to 0.72) in the intervention group at 24 weeks, which was reported to be significantly different (P = 0.02). This indicated a stability of cognitive function in the intervention group and a decline in the control group. The most common adverse events were fatigue, alopecia, nausea and headache; there was no difference in the adverse events reported between groups (risk ratio (RR) 1.00; 95% CI 0.76 to 1.32). It was noted that more participants in the memantine group were receiving steroids at entry into the study than the control group (P = 0.05), which may have indicated more symptoms and mass effect from brain metastases in the memantine group and would be expected to portend worse cognitive outcome at this time point, although this difference in steroid use did not continue over time. </p> </section> <section id="CD011335-sec-0084"> <h6 class="title">d‐threo‐methylphenidate hydrochloride (d‐MPH) versus placebo</h6> <p><a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a> evaluated d‐MPH, a central nervous system (CNS) stimulant that acts as a norepinephrine‐dopamine reuptake inhibitor, compared with placebo in patients with primary or metastatic brain tumours. Mean cognitive functioning, as assessed with the Mini‐Mental State Examination (MMSE), in the control group ranged from 26.5 (3.39 SD) to 27.8 (6.12 SD) at the end of radiation to 25.6 (11.54 SD) at eight weeks follow‐up. Mean overall cognitive functioning in the intervention group ranged from 27.2 (2.92 SD) at baseline to 26.4 (5.92 SD) at the end of radiation to 23.3 (10.46 SD) at eight weeks follow‐up. This difference was not significant and the standard deviation of mean change could not be calculated as P values were not reported. No other measures of cognitive performance were used, and it is noted that the MMSE is not considered a sensitive measure of cognitive function (<a href="./references#CD011335-bbs2-0088" title="MeyersCA , WefelJS . The use of the Mini-Mental State Examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. Journal of Clinical Oncology2003;21(19):3557-8.">Meyers 2003</a>). Fatigue was the primary outcome in this study, but was not found to be significantly different between groups at eight weeks follow‐up of drug use (mean difference (MD) 3.30, 95% CI ‐10.37 to 16.97). Depression and quality of life were also assessed, reporting no significant difference between groups, although again P values were not provided. Four adverse events were reported in total, although they were not all reported specifically to the arm and therefore the risk ratio could not be calculated; two participants experienced nausea and vomiting, one participant experienced tachycardia (control arm) and one participant was withdrawn from the study due to an increase in liver enzymes. </p> </section> </section> <section id="CD011335-sec-0085"> <h5 class="title">Non‐Pharmacological Studies</h5> <section id="CD011335-sec-0086"> <h6 class="title">Cognitive rehabilitation versus standard care</h6> <p><a href="./references#CD011335-bbs2-0005" title="LockeDEC , CerhanJH , WuW , MalecJF , ClarkMM , Rummans TA, et al. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumours: a pilot study. Journal of Supportive Oncology2008;6(8):383-91. ">Locke 2008</a> evaluated a two‐week cognitive rehabilitation and problem‐solving program, compared with standard care in patients with primary brain tumours. Control participants were reported as more significantly impaired on a measure of immediate memory than intervention participants at baseline (P = 0.03). Using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), the mean total cognitive functioning score remained stable at 73 from baseline (SD 13.4) to post‐intervention (SD 9.3) in the control groups and improved from 79 (SD 20.0) at baseline to 80 (SD 18.6) at post‐intervention in the intervention group; a statistical comparison was not carried out. Mood, fatigue, quality of life and caregiver burden measures were also recorded, but again no statistical comparisons were made. The primary outcomes of the study were feasibility, strategy implementation and patient satisfaction; 7/8 of the intervention group participants were using strategies at least once per week at the eight‐week follow‐up and 7/8 of both the participants and the caregivers found the intervention 'very helpful'. </p> </section> <section id="CD011335-sec-0087"> <h6 class="title">Calorie‐restricted ketogenic diet with intermittent fasting versus standard diet</h6> <p><a href="./references#CD011335-bbs2-0008" title="VossM , WengerKJ , vonMettenheimN , BojungaJ , VetterM , DiehlB , et al. Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial. European Journal of Nutrition2022;61(1):477-87. [DOI: 10.1007/s00394-021-02666-1]">Voss 2022</a> evaluated the effect of a calorie‐restricted ketogenic diet with intermittent fasting compared to a standard diet in patients with recurrent glioblastoma. Cognition was evaluated using the MMSE and d2 Test of Attention. Median MMSE scores were reported to not be significantly different between baseline and follow‐up for both groups (median = 29 points in both groups). However, baseline evaluation with the d2 Test of Attention revealed severely impaired median cognitive function percentile corrected for age, 5% (range: &lt;1 to 42%) in the intervention group and 16% (range: &lt;1 to 76%) in the standard diet group. At day 6, a non‐significant increase in d2 Test of Attention scores was found in both groups, with a median age‐corrected attention score of 12% in the intervention group (P = 0.187) and 23.5% in the standard diet group (P = 0.103). These scores increased significantly until one‐month follow‐up, with median age‐correct attention scores of 17% in the intervention group (P = 0.035) and 27% in the standard diet group (P = 0.049). Cognitive function was not affected by the diet. Of note, the standard diet group had a lower calorie intake than expected, 21 kcal per kg per day instead of 30 kcal per kg per day. Significant metabolic changes were found. Adverse events were reported in an original paper focusing on the primary outcome of the trial (<a href="./references#CD011335-bbs2-0122" title="VossM , WagnerM , vonMettenheimN , HarterPN , WengerKJ , FranzK , et al. ERGO2: A rospective, randomized trial of calorie-restricted ketogenic diet and Fasting in addition to reirradiation for malignant glioma. International Journal of Radiation Oncology, Biology, Physics2020;108(4):987–95. [DOI: 10.1016/j.ijrobp.2020.06.021]">Voss 2020</a>); until day 12, nine adverse events were reported (four in the intervention group and five in the standard diet group), three of which were seizures and the remainder were headaches, nausea, and possible epileptic seizures. From day 12 until one month, 11 adverse events were reported (five in the intervention group, six in the standard diet group), the majority of which were epileptic seizures (five focal epileptic seizures). </p> </section> </section> </section> <section id="CD011335-sec-0088"> <h4 class="title">Amelioration</h4> <section id="CD011335-sec-0089"> <h5 class="title">Pharmacological Studies</h5> <p>Due to the differences in control groups or differences in the drug investigated, pooling of the data was inappropriate. Therefore, results of the studies are reviewed separately. </p> <section id="CD011335-sec-0090"> <h6 class="title">Modafinil at two different doses</h6> <p><a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a>, published as a conference abstract only, compared two doses of the CNS stimulant modafinil, 200 mg/day or 400 mg/day in divided doses, in patients with primary brain tumours. A significant improvement from baseline was seen at 12 weeks across all cognitive tests; Trail Making Test A (P = 0.002) and B (P &lt; 0.0001), Verbal Fluency (P = 0.002) and Symbol Digit Modalities‐Oral (P = 0.006) and ‐Manual (P = 0.004). Significant differences were also found at eight weeks for all tests. Improvements in fatigue and mood were found at eight and 12 weeks. Adverse events were reported, however the distribution of adverse events between treatment arms was not reported. Thirteen participants experienced symptoms of headache, eight of insomnia, seven of dizziness, seven of dry mouth, five of depressed consciousness and four of nausea. </p> </section> <section id="CD011335-sec-0091"> <h6 class="title">Methylphenidate versus modafinil</h6> <p><a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a> compared two CNS stimulants, in three treatment arms; sustained‐release methylphenidate, immediate‐release methylphenidate and modafinil in patients with primary brain tumours. The mean cognitive functioning scores comparison for each test is summarised in <a href="./references#CD011335-fig-0018" title="">Analysis 4.2</a>; Digit Span (MD 0.38; 95% CI 0.03 to 0.73), favouring methylphenidate, and Trail Making Test A (MD ‐2.48, 95% CI ‐4.82 to ‐0.14), favouring modafinil were the only tests to show a significant difference between groups. The two stimulant groups together demonstrated significant improvement of individual Trail Making Test B scores P = &lt; 0.01), corrected for practice effects. Mood, fatigue, quality of life and sleep also significantly improved in both groups, but with no significant difference between groups (see <a href="./references#CD011335-fig-0021" title="">Analysis 4.5</a>; <a href="./references#CD011335-fig-0022" title="">Analysis 4.6</a>; <a href="./references#CD011335-fig-0024" title="">Analysis 4.8</a>; <a href="./references#CD011335-fig-0025" title="">Analysis 4.9</a>; <a href="./references#CD011335-fig-0027" title="">Analysis 4.11</a>). None of the participants who completed the study experienced adverse events in either treatment arm. </p> </section> <section id="CD011335-sec-0092"> <h6 class="title">Donepezil versus placebo</h6> <p><a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a> compared donepezil, an acetylcholinesterase inhibitor, with placebo in patients with primary and metastatic brain tumours, and patients undergoing prophylactic cranial irradiation. The mean cognitive functioning score comparison for each test is reported in <a href="./references#CD011335-fig-0029" title="">Analysis 5.2</a>, based on raw data provided by the authors. The primary outcome was a calculated cognitive composite score, in which both groups were found to significantly improve after 24 weeks; there was no significant difference between groups (MD 0.03, 95% CI ‐0.06 to 0.13). A significant difference was found in scores of tests of long‐term memory recognition (MD 0.57, 95% CI 0.07 to 1.07), long‐term memory discrimination (MD 0.94, 95% CI 0.26 to 1.62), and dominant hand psychomotor functioning (MD ‐11.92, 95% CI ‐21.58 to ‐2.27) favouring donepezil. Furthermore, the benefits of donepezil were greater for those who were more cognitively impaired prior to study treatment. The commonest toxicity reported was fatigue (58% of those receiving donepezil and 67% receiving placebo), and the only toxicity that was significantly different between the two arms was diarrhoea (25% of those receiving donepezil and 9% receiving placebo; P = 0.005).  </p> </section> </section> <section id="CD011335-sec-0093"> <h5 class="title">Non‐Pharmacological Studies</h5> <section id="CD011335-sec-0094"> <h6 class="title">Goal Management Training versus active control and wait‐list control</h6> <p><a href="./references#CD011335-bbs2-0007" title="RichardNM , BernsteinLJ , MasonWP , LaperriereN , MauriceC , MillarBA , et al. Cognitive rehabilitation for executive dysfunction in brain tumor patients: a pilot randomized controlled trial. Journal of Neuro oncology2019;142(3):565-75. [DOI: 10.1007/s11060-019-03130-1]">Richard 2019</a> compared Goal Management Training, an active control (Brain Health Program) and a wait‐list control group in patients with primary brain tumours. The comparison in group changes from baseline to immediately post‐training and four‐month follow‐up for the cognitive performance measures is summarised in <a href="#CD011335-tbl-0002">Table 2</a>, and analyses for the cognitive performance measures (executive functioning composite, memory composite and processing speed) as well as the self‐reported outcome measures are shown in <a href="./references#CD011335-fig-0031" title="">Analysis 6.1</a>; <a href="./references#CD011335-fig-0032" title="">Analysis 6.2</a>; <a href="./references#CD011335-fig-0033" title="">Analysis 6.3</a>; <a href="./references#CD011335-fig-0034" title="">Analysis 6.4</a>; <a href="./references#CD011335-fig-0035" title="">Analysis 6.5</a>; <a href="./references#CD011335-fig-0036" title="">Analysis 6.6</a>. A significant intervention effect on the executive composite was observed at four months follow‐up (with a time‐by‐group interaction F(2,16) = 3.760, P = 0.046, partial eta‐squared value = 0.320), which reflected a large improvement in the Goal Management Training group (effect size = 1.08, P = 0.002, corrected effect size = 1.09) and minimal change in the Brain Health Program (effect size = 0.09, P &gt; 0.1) and wait‐control (effect size = ‐0.06, P &gt; 0.1) groups. There was a statistically significant difference in the proportion of participants that scored in the impaired range on one or more tests of executive functioning between groups by follow‐up (Goal Management Training: 91% at baseline to 20% at four months; Brain Health Program, 88% at baseline to 67% at four months; wait‐list control, 100% throughout; chi‐square value = 7.234, P = 0.027). For the memory composite, all groups improved at follow‐up (main effect of time: F(1,16) = 6.435, P &lt; 0.001, partial eta‐squared = 0.524). Effect sizes were moderate to large, although within‐group simple effects tests for the Brain Health Program and wait‐list control groups were not significant (Goal Management Training effect size = 1.37, P &gt; 0.002; Brain Health Program effect size = 0.74, P = 0.093; wait‐list control effect size = 1.06, P &gt; 0.1). Regarding processing speed, at follow‐up the Goal Management Training group had moderate gains relative to baseline (effect size = 0.61, P = 0.015, corrected effect size = 0.68), whereas no improvement was observed in the Brain Health Program (effect size = ‐0.09, P &gt; 0.1) and wait‐list control (effect size = ‐0.30, P &gt; 0.1) groups. Both the Goal Management Training and Brain Health Program groups reported fewer cognitive concerns immediately post‐training (P = 0.049) and at 4‐months follow‐up (P &lt; 0.001). </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011335-sec-0095" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011335-sec-0095"></div> <section id="CD011335-sec-0096"> <h3 class="title" id="CD011335-sec-0096">Summary of main results</h3> <p>The aim of this review was to evaluate the effect of any pharmacological or non‐pharmacological intervention on cognitive functioning during or following cranial irradiation. In the original review, we included three randomised trials for the prevention of cognitive deficits, recruiting a total of 641 heterogeneous patients and three randomised trials for the amelioration of cognitive deficits, recruiting a total of 199 heterogeneous patients. In this update, we included an additional randomised trial for preventing cognitive deficits that recruited 50 patients and an additional trial for ameliorating cognitive defects that randomised 25 patients. </p> <section id="CD011335-sec-0097"> <h4 class="title">Prevention</h4> <p>The two trials that compared drug versus placebo used very different drug agents, dosage schedules and time points for follow‐up; a meta‐analysis was therefore inappropriate. </p> <p><a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a> compared memantine in a large sample of 554 patients with brain metastases from 143 centres across the USA and Canada, and carried out imputation in participants who had not withdrawn from the study as a result of death. The primary outcome measure, memory as measured using the Hopkins Verbal Learning Test‐Revised (HVLT‐R for Delayed Recall) at 23 weeks, showed a non‐significantly reduced rate of decline in the memantine group. Significant differences between groups were found in other cognitive domains.  </p> <p><a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a> compared d‐threo‐methylphenidate hydrochloride (d‐MPH) in a small sample of 68 patients with primary and metastatic brain tumours with a high drop‐out rate; no difference was found between the intervention group and control group in the primary outcome (fatigue), or in cognitive functioning, depression and quality of life. </p> <p>The one prevention trial that investigated a cognitive rehabilitation and problem‐solving program, compared with standard care, had the primary aim of assessing the tolerability and feasibility of the intervention (<a href="./references#CD011335-bbs2-0005" title="LockeDEC , CerhanJH , WuW , MalecJF , ClarkMM , Rummans TA, et al. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumours: a pilot study. Journal of Supportive Oncology2008;6(8):383-91. ">Locke 2008</a>). Therefore, no statistical comparisons were made of the difference between groups in cognitive functioning. Consequently, this study provides very little evidence for the prevention of cognitive deficits, but did offer a tolerable and feasible intervention for further investigation. </p> <p><a href="./references#CD011335-bbs2-0008" title="VossM , WengerKJ , vonMettenheimN , BojungaJ , VetterM , DiehlB , et al. Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial. European Journal of Nutrition2022;61(1):477-87. [DOI: 10.1007/s00394-021-02666-1]">Voss 2022</a> compared calorie‐restricted ketogenic diet and intermittent fasting to standard diet in 50 patients undergoing re‐irradiation for glioblastoma. The study's primary endpoint measure was progression‐free survival at six months (reported in a different manuscript), and cognitive functioning was evaluated as one of several secondary endpoints. The study found no significant change in the primary endpoint measure, or in median Mini‐Mental State Examination (MMSE) scores in either group, at baseline and at follow‐up. Attention was severely impaired at baseline but increased significantly until follow‐up at one month in both groups. Cognitive function was not affected by the diet, and the standard diet group had a lower calorie intake than expected, which complicated interpretation of the results. </p> </section> <section id="CD011335-sec-0098"> <h4 class="title">Amelioration</h4> <p>The three pharmacological trials that investigated the amelioration of cognitive deficits used different drug agents and/or control groups and different time points for follow‐up; a meta‐analysis was therefore inappropriate. </p> <p><a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a> compared two forms of methylphenidate with modafinil, in a small sample of 24 mostly glioma patients. Inconsistent, differential effects were found in cognitive performance between groups in attention, favouring methylphenidate, and processing speed, favouring modafinil. However, when treatment groups were combined, and after corrections for practice effects, there was evidence of a beneficial effect on test performance in speed of processing and executive function requiring divided attention. </p> <p><a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a>, published as a conference abstract, also combined intervention arms in a study of 30 patients with mainly gliomas and found an overall significant improvement (but without correction of practice effects) in all cognitive assessments at eight and 12 weeks, compared to baseline.  </p> <p><a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a> with a larger sample size (146 patients, from 24 sites, with primary or metastatic brain tumours or receiving prophylactic cranial irradiation) than either <a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a> or <a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a> compared donepezil with placebo. Treatment with donepezil did not significantly improve the primary outcome measure, a cognitive composite score, but did result in modest improvements in several cognitive functions, especially among patients with greater pre‐treatment impairments. However, the clinical relevance of some of these improvements, particularly in the HVLT‐R, are unclear. </p> <p>Only one study investigated the amelioration of cognitive deficits via a non‐pharmacological intervention. <a href="./references#CD011335-bbs2-0007" title="RichardNM , BernsteinLJ , MasonWP , LaperriereN , MauriceC , MillarBA , et al. Cognitive rehabilitation for executive dysfunction in brain tumor patients: a pilot randomized controlled trial. Journal of Neuro oncology2019;142(3):565-75. [DOI: 10.1007/s11060-019-03130-1]">Richard 2019</a> compared two active interventions, Goal Management Training and Brain Health Program, to a wait‐list control group in a group of 25 patients with primary brain tumours from a single Canadian centre. The study found executive functions improved only in the Goal Management Training group and were maintained at four months follow‐up. Processing speed also improved in the Goal Management Training and Brain Health Program groups, although this was only maintained at four months in the Goal Management Training group. All three groups improved in the memory tests, suggesting a practice effect. </p> </section> </section> <section id="CD011335-sec-0099"> <h3 class="title" id="CD011335-sec-0099">Overall completeness and applicability of evidence</h3> <p>We included eight randomised controlled trials (RCTs) examining the efficacy of interventions for the prevention or amelioration of cognitive deficits in adults treated with cranial irradiation. Due to differences in drug agents, it was inappropriate to combine data into a meta‐analysis.  </p> <p>The evidence identified in this review is insufficient to address the objective of this review and to make generalisations about the applicability (external validity) of the described interventions to the wider population of patients with brain tumours that have received cranial irradiation. This is due in part to the low sample sizes of several of the included studies, as well as the wide heterogeneity in study populations, interventions, study designs, outcome measures and timing of assessments. Most of the included studies were restricted by these and the following limitations, which further reduced both the internal and external validity of the evidence; it is also of note that the completeness of the evidence is hampered by the lack of randomised studies evaluating interventions such as exercise therapy, hyperbaric oxygen therapy and dietary supplements. </p> <p>Several of the studies included in this review were at high risk of bias in at least one domain. Generally, the non‐pharmacological studies were more likely to be at high risk of bias due to the nature of the intervention and the inability to provide a placebo condition. This negatively affected the internal validity of the included studies. </p> <p>Many studies were limited by low accrual. Studies that recruited from few centres were unable to reach the necessary number of participants required for sufficient statistical power (<a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>; <a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>; <a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a>; <a href="./references#CD011335-bbs2-0005" title="LockeDEC , CerhanJH , WuW , MalecJF , ClarkMM , Rummans TA, et al. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumours: a pilot study. Journal of Supportive Oncology2008;6(8):383-91. ">Locke 2008</a>). It may also be that patients may be reluctant to take any additional medication, especially if they are not subjectively experiencing cognitive impairment at the time of enrolment. </p> <p>Most studies were limited by high attrition rates. One study was able to recruit the projected participants required for 80% statistical power with the involvement of 143 centres (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>). However, 34% of participants died at 24 weeks of drug use and 47% of the remaining 280 participants missed their assessment appointment. It is important to understand the reasons for missed appointments. For example, in studies that focus on prevention rather than treatment, a lack of interest may be found in patients not experiencing cognitive impairment at that stage. Therefore, it is important to make sufficient attempts to keep patients engaged in study participation, such as by emphasising the importance of ongoing cognitive function assessment. It is also notable that, in some studies, patients withdrawing from the trial tended to be older, and/or had worse performance status/neurological function and/or had shorter survival. </p> <p>Differences in the time points at which cognitive functioning is measured are also present, both in pharmacological and non‐pharmacological intervention studies. One study carried out assessments at baseline, and at four weeks of modafinil or methylphenidate use (<a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>), whereas another continued to follow up patients at eight, 16, 24 and 52 weeks following initiation of the drug memantine (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>). In cognitive rehabilitation studies, patients were assessed at baseline and at the end of a two‐week intervention and at three months (<a href="./references#CD011335-bbs2-0005" title="LockeDEC , CerhanJH , WuW , MalecJF , ClarkMM , Rummans TA, et al. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumours: a pilot study. Journal of Supportive Oncology2008;6(8):383-91. ">Locke 2008</a>). These studies also demonstrate the variations in duration of the intervention.  </p> <p>Only one study mentioned specifically attempting to minimise practice effects (<a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>). </p> <p>A number of assessment tools were used to evaluate cognitive function in the included studies, ranging from a battery of numerous tests (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>; <a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>; <a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a>; <a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a>; <a href="./references#CD011335-bbs2-0007" title="RichardNM , BernsteinLJ , MasonWP , LaperriereN , MauriceC , MillarBA , et al. Cognitive rehabilitation for executive dysfunction in brain tumor patients: a pilot randomized controlled trial. Journal of Neuro oncology2019;142(3):565-75. [DOI: 10.1007/s11060-019-03130-1]">Richard 2019</a>), to the MMSE and d2 Test of Attention (<a href="./references#CD011335-bbs2-0008" title="VossM , WengerKJ , vonMettenheimN , BojungaJ , VetterM , DiehlB , et al. Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial. European Journal of Nutrition2022;61(1):477-87. [DOI: 10.1007/s00394-021-02666-1]">Voss 2022</a>), or the MMSE (<a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>) or RBANS (<a href="./references#CD011335-bbs2-0005" title="LockeDEC , CerhanJH , WuW , MalecJF , ClarkMM , Rummans TA, et al. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumours: a pilot study. Journal of Supportive Oncology2008;6(8):383-91. ">Locke 2008</a>) alone.  The use of a single cognitive outcome measure is unlikely to fully and comprehensively represent a participant's cognitive status. In addition, although neuropsychological tests provide objective evidence of cognitive performance, it is largely unclear whether any improvements in test scores translate to genuine long‐term benefits in everyday life/quality of life. More extensive and longer‐term study of neuropsychological performance alongside self‐ and caregiver‐reported measures are required to elucidate further on this issue. </p> <p>Failure to report all study and patient characteristics meant that limitations remained a concern. The lack of adequately presented data, or lack of reporting of mean differences and standard deviation or P values, meant that the reporting of results as per the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011335-bbs2-0076" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>) could not be carried out in five studies (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>; <a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>;  <a href="./references#CD011335-bbs2-0004" title="KaleitaTA , WellischDK , GrahamCA , StehB , Nghiemphu, Ford JM et, al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. In: Journal of Clinical Oncology. Vol. 24. 2006:1503. ">Kaleita 2006</a>; <a href="./references#CD011335-bbs2-0005" title="LockeDEC , CerhanJH , WuW , MalecJF , ClarkMM , Rummans TA, et al. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumours: a pilot study. Journal of Supportive Oncology2008;6(8):383-91. ">Locke 2008</a>; <a href="./references#CD011335-bbs2-0008" title="VossM , WengerKJ , vonMettenheimN , BojungaJ , VetterM , DiehlB , et al. Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial. European Journal of Nutrition2022;61(1):477-87. [DOI: 10.1007/s00394-021-02666-1]">Voss 2022</a>). Further correspondence to obtain these data were unsuccessful. The use and changes in use of medications associated with cognitive functioning were rarely reported. Only one study reported the use, and change in use of steroids during participation (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>), and reported that more intervention participants were receiving steroids at study entry than control participants. No studies reported the use, or change in use of anti‐epileptic drugs during participation. As these drugs may also play a role in cognitive functioning (<a href="./references#CD011335-bbs2-0079" title="KirkmanMA , HunnBH , ThomasMS , TolmieAK . Influences on cognitive outcomes in adult patients with gliomas: a systematic review. Frontiers in Oncology2022;12:943600.">Kirkman 2022</a>), findings may be attributable to changes in these medications during the study period. Assessment of cognitive functioning following withdrawal of the drug under study may have provided additional information relating to the efficacy of the drug. Two studies carried out post‐drug withdrawal assessments (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>; <a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>), but these data were not reported. </p> </section> <section id="CD011335-sec-0100"> <h3 class="title" id="CD011335-sec-0100">Quality of the evidence</h3> <p>See <a href="#CD011335-fig-0002">Figure 2</a> and <a href="#CD011335-fig-0003">Figure 3</a>. </p> <p>Overall, this review summarises limited evidence for the effect of pharmacological and non‐pharmacological interventions for the prevention or amelioration of cognitive deficits in adults treated with cranial irradiation. Two of the studies were at high risk of bias in three or more domains, with additional domains at an unclear risk of bias (<a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>; <a href="./references#CD011335-bbs2-0005" title="LockeDEC , CerhanJH , WuW , MalecJF , ClarkMM , Rummans TA, et al. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumours: a pilot study. Journal of Supportive Oncology2008;6(8):383-91. ">Locke 2008</a>). Blinding was not carried out in four studies (<a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>; <a href="./references#CD011335-bbs2-0005" title="LockeDEC , CerhanJH , WuW , MalecJF , ClarkMM , Rummans TA, et al. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumours: a pilot study. Journal of Supportive Oncology2008;6(8):383-91. ">Locke 2008</a>; <a href="./references#CD011335-bbs2-0007" title="RichardNM , BernsteinLJ , MasonWP , LaperriereN , MauriceC , MillarBA , et al. Cognitive rehabilitation for executive dysfunction in brain tumor patients: a pilot randomized controlled trial. Journal of Neuro oncology2019;142(3):565-75. [DOI: 10.1007/s11060-019-03130-1]">Richard 2019</a>; <a href="./references#CD011335-bbs2-0008" title="VossM , WengerKJ , vonMettenheimN , BojungaJ , VetterM , DiehlB , et al. Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial. European Journal of Nutrition2022;61(1):477-87. [DOI: 10.1007/s00394-021-02666-1]">Voss 2022</a>) and, in two studies, randomisation could not be concluded (<a href="./references#CD011335-bbs2-0003" title="GehringK , PatwardhanSY , CollinsR , GrovesMD , EtzelCJ , MeyersCA , et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-oncology2012;107(1):165-74. [DOI: 10.1007/s11060-011-0723-1]">Gehring 2012a</a>) or was abandoned (<a href="./references#CD011335-bbs2-0005" title="LockeDEC , CerhanJH , WuW , MalecJF , ClarkMM , Rummans TA, et al. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumours: a pilot study. Journal of Supportive Oncology2008;6(8):383-91. ">Locke 2008</a>). Four RCTs were at a low risk of bias across all (<a href="./references#CD011335-bbs2-0001" title="BrownPD , PughS , LaackNN , WefelJS , KhuntiaD , MeyersC , et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology2013;15(10):1429-37. [DOI: 10.1093/neuonc/not114]">Brown 2013</a>; <a href="./references#CD011335-bbs2-0002" title="Butler JM Jr, CaseLD , AtkinsJ , FrizzellB , SandersG , GriffinP , et al. A phase III, double-blind, placebo-controlled prospective randomised clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Internation Journal of Radiation Oncology *Biology *Physics2007;69(5):1496-501. [DOI: 10.1016/j.ijrobp.2007.05.076]">Butler 2007</a>; <a href="./references#CD011335-bbs2-0006" title="RappSR , CaseLD , PeifferA , NaughtonMM , ChanMD , StieberVW , et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. Journal of Clinical Oncology2015;33(15):1653-9. ">Rapp 2015</a>) or almost all (<a href="./references#CD011335-bbs2-0007" title="RichardNM , BernsteinLJ , MasonWP , LaperriereN , MauriceC , MillarBA , et al. Cognitive rehabilitation for executive dysfunction in brain tumor patients: a pilot randomized controlled trial. Journal of Neuro oncology2019;142(3):565-75. [DOI: 10.1007/s11060-019-03130-1]">Richard 2019</a>) domains. </p> <p>Although a formal GRADE assessment was not conducted as part of this review, it is clear from the above evaluation of the studies that the evidence identified is largely of 'low' and 'very low' certainty, indicating that any new evidence is likely to have an impact on the existing results; this reinforces the need for further high‐quality studies evaluating interventions to prevent and improve cognitive dysfunction in adult patients that have received cranial irradiation. </p> </section> <section id="CD011335-sec-0101"> <h3 class="title" id="CD011335-sec-0101">Potential biases in the review process</h3> <p>We carried out extensive searches in four databases, which included published studies and conference proceedings as well as searching the reference lists of included studies. However, we may have failed to identify all eligible studies. We were somewhat successful in our attempts to obtain further information about the methodology of the studies by emailing the authors. Overall, our attempts to obtain further data on the included studies did not allow us to report all studies as per the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011335-bbs2-0076" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). </p> </section> <section id="CD011335-sec-0102"> <h3 class="title" id="CD011335-sec-0102">Agreements and disagreements with other studies or reviews</h3> <p>In the search results we found one other review reporting interventions for preventing or ameliorating cognitive deficits in adults treated with cranial irradiation (<a href="./references#CD011335-bbs2-0114" title="TalletA , DhermainF , TailliaH , RicardD , MornexF , MétellusP . Cognition and radiation therapy for brain metastases: a new paradigm to define [Cognition et radiothérapie dans les métastases cérébrales: un nouveau paradigme à définir]. Bulletin du Cancer2013;100(1):63-9. [DOI: 10.1684/bdc.2012.1682]">Tallet 2013</a>), but did not find any additional studies from the review that were eligible to include in this review. </p> <p>Other reviews identified were associated more generally with all brain tumour patients, all cancer patients, or more widely in all clinical conditions, who had not necessarily received cranial irradiation. For example, <a href="./references#CD011335-bbs2-0064" title="GehringK , SitskoornMM , AaronsonNK , TaphoornMJ . Interventions for cognitive deficits in adults with brain tumours. Lancet Neurology2008;7(6):548-60.">Gehring 2008</a> conducted a systematic review of interventions for cognitive deficits in patients with all types of brain tumour. <a href="./references#CD011335-bbs2-0054" title="DavidJ , AhlbergFM , BerkM , AshleyDM , KhasrawM . Emerging pharmacotherapy for cancer patients with cognitive dysfunction. BMC Neurology2013;13(1):153.">Davis 2013</a> and <a href="./references#CD011335-bbs2-0066" title="GehringK , RoukemaJA , SitskoornMM . Review of recent studies on interventions for cognitive deficits in patients with cancer. Expert Review of Anticancer Therapy2012;12(2):255-69. [DOI: 10.1586/era.11.202]">Gehring 2012b</a> conducted reviews of ongoing studies investigating pharmacological interventions to treat cancer patients with cognitive dysfunction. <a href="./references#CD011335-bbs2-0106" title="RooneyJW , LaackNN . Pharmacological interventions to treat or prevent neurocognitive decline after brain radiation. CNS Oncology2013;2(6):531-41.">Rooney 2014</a> reviewed pharmacological interventions to treat or prevent neurocognitive decline after brain radiation. <a href="./references#CD011335-bbs2-0044" title="ChallmanTD , LipskyJJ . Methylphenidate: its pharmacology and uses. Mayo Clinic Proceedings2000;75(7):711-21.">Challman 2000</a> reviewed the use of methylphenidate in many clinical conditions, including patients with a brain tumour. <a href="./references#CD011335-bbs2-0126" title="WefelJS , KeslerSR , NollKR , SchagenSB . Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.. CA: a Cancer Journal for Clinicians2015;65(2):123-38.">Wefel 2015</a> reviewed evidence relating to cognitive impairment in patients with non‐CNS tumours and focused on patients with breast cancer. <a href="./references#CD011335-bbs2-0048" title="CoomansMB , van derLindenSD , GehringK , TaphoornMB . Treatment of cognitive deficits in brain tumour patients: current status and future directions. Current Opinion in Oncology2019;31(6):540-7.">Coomans 2019</a> reviewed studies of antitumour treatment strategies that aimed to prevent or minimise cognitive deficits in brain tumour patients and incorporated all treatment modalities, including surgery and chemotherapy. <a href="./references#CD011335-bbs2-0077" title="KarschniaP , ParsonsMW , DietrichJ . Pharmacologic management of cognitive impairment induced by cancer therapy. Lancet Oncology2019;20(2):e92-102.">Karschnia 2019</a> focused on the pharmacologic management of cognitive impairment induced by cancer therapy. </p> <p>The studies included in these reviews did not provide additional evidence specifically for cranial irradiated patients. Similar conclusions were made, emphasising that the evidence is limited by significant methodological limitations; such as the absence of a control group, lack of statistical comparisons between groups when control groups were present (due to small sample sizes), the use of unreliable cognitive tests, and the overall need for larger trials with more statistical power. <a href="./references#CD011335-bbs2-0066" title="GehringK , RoukemaJA , SitskoornMM . Review of recent studies on interventions for cognitive deficits in patients with cancer. Expert Review of Anticancer Therapy2012;12(2):255-69. [DOI: 10.1586/era.11.202]">Gehring 2012b</a> suggested the use of home assessments and/or Internet‐based programmes as potential solutions to help with accrual and attrition. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011335-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-FIG-01" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD011335-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/full#CD011335-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011335-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/full#CD011335-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011335-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/full#CD011335-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0004"> <p> <div class="table" id="CD011335-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Cognitive functioning composite score</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 1</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 2</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 3</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 4</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 5</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Brown 2013</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Prevention: Memantine versus placebo, Outcome 1: Cognitive functioning composite score </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0004">Navigate to figure in review</a></div> </div> <div class="figure" id="CD011335-fig-0005"> <p> <div class="table" id="CD011335-tblf-0002"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>Cognitive functioning sub‐tests</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 1</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 2</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 3</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 4</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 5</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 6</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 7</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Short‐term verbal memory</b> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="7" scope="col" valign=""> <p><b>Brown 2013</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Long‐term verbal memory (recall)</b> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="7" scope="col" valign=""> <p><b>Brown 2013</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Long‐term verbal memory (recognition)</b> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="7" scope="col" valign=""> <p><b>Brown 2013</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Trail making test A</b> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="7" scope="col" valign=""> <p><b>Brown 2013</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Trail making test B</b> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="7" scope="col" valign=""> <p><b>Brown 2013</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Verbal fluency</b> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="7" scope="col" valign=""> <p><b>Brown 2013</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Prevention: Memantine versus placebo, Outcome 2: Cognitive functioning sub‐tests </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0005">Navigate to figure in review</a></div> </div> <div class="figure" id="CD011335-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Prevention: Memantine versus placebo, Outcome 3: Adverse events" data-id="CD011335-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Prevention: Memantine versus placebo, Outcome 3: Adverse events</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0007"> <p> <div class="table" id="CD011335-tblf-0003"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>General cognitive functioning</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 1</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 2</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 3</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 4</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 5</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Butler 2007</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Prevention: d‐threo‐methylphenidate versus placebo, Outcome 1: General cognitive functioning </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0007">Navigate to figure in review</a></div> </div> <div class="figure" id="CD011335-fig-0008"> <p> <div class="table" id="CD011335-tblf-0004"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Depression</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 1</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 2</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 3</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 4</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 5</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Butler 2007</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Prevention: d‐threo‐methylphenidate versus placebo, Outcome 2: Depression</p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0008">Navigate to figure in review</a></div> </div> <div class="figure" id="CD011335-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Prevention: d‐threo‐methylphenidate versus placebo, Outcome 3: Fatigue" data-id="CD011335-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Prevention: d‐threo‐methylphenidate versus placebo, Outcome 3: Fatigue</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0010"> <p> <div class="table" id="CD011335-tblf-0005"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Quality of life</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 1</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 2</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 3</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 4</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 5</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>FACT</b> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Butler 2007</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Brain subscale</b> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Butler 2007</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Prevention: d‐threo‐methylphenidate versus placebo, Outcome 4: Quality of life </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0010">Navigate to figure in review</a></div> </div> <div class="figure" id="CD011335-fig-0011"> <p> <div class="table" id="CD011335-tblf-0006"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Cognitive functioning</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 1</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 2</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 3</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 4</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 5</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Locke 2008</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Prevention: Cognitive rehabilitation versus standard care, Outcome 1: Cognitive functioning </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0011">Navigate to figure in review</a></div> </div> <div class="figure" id="CD011335-fig-0012"> <p> <div class="table" id="CD011335-tblf-0007"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Cognitive functioning sub‐test</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 1</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 2</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 3</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 4</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 5</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Attention</b> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Locke 2008</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Short‐term verbal memory</b> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Locke 2008</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Short‐term visual memory</b> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Locke 2008</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Long‐term verbal/visual memory</b> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Locke 2008</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Language</b> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Locke 2008</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Prevention: Cognitive rehabilitation versus standard care, Outcome 2: Cognitive functioning sub‐test </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0012">Navigate to figure in review</a></div> </div> <div class="figure" id="CD011335-fig-0013"> <p> <div class="table" id="CD011335-tblf-0008"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Mood</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 1</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 2</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 3</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 4</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 5</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Locke 2008</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Prevention: Cognitive rehabilitation versus standard care, Outcome 3: Mood </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0013">Navigate to figure in review</a></div> </div> <div class="figure" id="CD011335-fig-0014"> <p> <div class="table" id="CD011335-tblf-0009"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Fatigue</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 1</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 2</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 3</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 4</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 5</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Locke 2008</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Prevention: Cognitive rehabilitation versus standard care, Outcome 4: Fatigue </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0014">Navigate to figure in review</a></div> </div> <div class="figure" id="CD011335-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Prevention: Cognitive rehabilitation versus standard care, Outcome 5: Functional capacity" data-id="CD011335-fig-0015" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: Prevention: Cognitive rehabilitation versus standard care, Outcome 5: Functional capacity </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-003.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Prevention: Cognitive rehabilitation versus standard care, Outcome 6: Quality of life" data-id="CD011335-fig-0016" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-003.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-003.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3: Prevention: Cognitive rehabilitation versus standard care, Outcome 6: Quality of life </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-003.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 1: Cognitive functioning (calculated score)" data-id="CD011335-fig-0017" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 1: Cognitive functioning (calculated score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 2: Cognitive functioning (timed tasks)" data-id="CD011335-fig-0018" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 2: Cognitive functioning (timed tasks) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 3: Cognitive functioning (total score)" data-id="CD011335-fig-0019" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 3: Cognitive functioning (total score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-004.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 4: Self‐reported confusion" data-id="CD011335-fig-0020" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-004.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 4: Self‐reported confusion </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-004.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 5: Anxiety" data-id="CD011335-fig-0021" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-004.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 5: Anxiety</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-004.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 6: Depression" data-id="CD011335-fig-0022" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-004.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 6: Depression</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-004.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 7: Anger" data-id="CD011335-fig-0023" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-004.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 7: Anger</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-004.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 8: Fatigue" data-id="CD011335-fig-0024" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-004.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 8: Fatigue</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-004.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 9: Sleep" data-id="CD011335-fig-0025" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-004.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.9</div> <div class="figure-caption"> <p>Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 9: Sleep</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-004.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 10: Activity" data-id="CD011335-fig-0026" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-004.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.10</div> <div class="figure-caption"> <p>Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 10: Activity</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-004.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 11: Quality of life" data-id="CD011335-fig-0027" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-004.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.11</div> <div class="figure-caption"> <p>Comparison 4: Amelioration: Methylphenidate versus modafinil, Outcome 11: Quality of life </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-004.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Amelioration: Donepezil versus placebo, Outcome 1: Cognitive composite score" data-id="CD011335-fig-0028" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Amelioration: Donepezil versus placebo, Outcome 1: Cognitive composite score </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Amelioration: Donepezil versus placebo, Outcome 2: Cognitive functioning (timed tasks)" data-id="CD011335-fig-0029" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: Amelioration: Donepezil versus placebo, Outcome 2: Cognitive functioning (timed tasks) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-005.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Amelioration: Donepezil versus placebo, Outcome 3: Cognitive functioning (total score)" data-id="CD011335-fig-0030" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-005.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-005.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5: Amelioration: Donepezil versus placebo, Outcome 3: Cognitive functioning (total score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-005.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Amelioration: Goal management training versus brain health program versus wait‐listed control, Outcome 1: Cognitive performance measures: Goal management training versus wait‐list control" data-id="CD011335-fig-0031" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: Amelioration: Goal management training versus brain health program versus wait‐listed control, Outcome 1: Cognitive performance measures: Goal management training versus wait‐list control </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Amelioration: Goal management training versus brain health program versus wait‐listed control, Outcome 2: Cognitive performance measures: Goal management training versus brain health program" data-id="CD011335-fig-0032" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: Amelioration: Goal management training versus brain health program versus wait‐listed control, Outcome 2: Cognitive performance measures: Goal management training versus brain health program </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-006.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Amelioration: Goal management training versus brain health program versus wait‐listed control, Outcome 3: Cognitive performance measures: Brain health program versus wait‐list control" data-id="CD011335-fig-0033" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-006.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-006.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6: Amelioration: Goal management training versus brain health program versus wait‐listed control, Outcome 3: Cognitive performance measures: Brain health program versus wait‐list control </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-006.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-006.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Amelioration: Goal management training versus brain health program versus wait‐listed control, Outcome 4: Patient‐reported outcome measures: Goal management training versus wait‐list control" data-id="CD011335-fig-0034" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-006.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-006.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6: Amelioration: Goal management training versus brain health program versus wait‐listed control, Outcome 4: Patient‐reported outcome measures: Goal management training versus wait‐list control </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-006.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-006.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Amelioration: Goal management training versus brain health program versus wait‐listed control, Outcome 5: Patient‐reported outcome measures: Goal management training versus brain health program" data-id="CD011335-fig-0035" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-006.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-006.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6: Amelioration: Goal management training versus brain health program versus wait‐listed control, Outcome 5: Patient‐reported outcome measures: Goal management training versus brain health program </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-006.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011335-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/urn:x-wiley:14651858:media:CD011335:CD011335-CMP-006.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Amelioration: Goal management training versus brain health program versus wait‐listed control, Outcome 6: Patient‐reported outcome measures: Brain health program versus wait‐list control" data-id="CD011335-fig-0036" src="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-006.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_t/tCD011335-CMP-006.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6: Amelioration: Goal management training versus brain health program versus wait‐listed control, Outcome 6: Patient‐reported outcome measures: Brain health program versus wait‐list control </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/media/CDSR/CD011335/image_n/nCD011335-CMP-006.06.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD011335-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of findings: Memantine versus placebo</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Cognitive functioning measure</b> </p> <p><b>(standardised scores)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Memantine</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p> </p> <p>P</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>N</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median change after 24 weeks (IQR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>N</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median change after 24 weeks (IQR)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short‐term verbal memory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.23 (‐1.16 to 0.70)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.415 (‐1.86 to 0.46)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long‐term verbal memory (recall)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 (‐1.67 to 0.59)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.90 (‐2.22 to 0.55)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.06</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long‐term verbal memory (recognition)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 (‐1.12 to 1.43)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.72 (‐2.73 to 0.71)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.01*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Verbal Fluency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.10 (‐0.62 to 0.53)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.16 (‐0.83 to 0.61)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.31</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trail Making Test A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.08 (‐1.01 to 1.82)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.37 (‐2.08 to 0.50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.02*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trail Making Test B</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.45 (‐2.37 to 1.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.49 (‐2.60 to 0.62)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cognitive composite score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.03 (‐0.90 to 0.72)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.41 (‐1.30 to 0.12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.02*</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>* P &lt; 0.05</p> <p>IQR: interquartile range<br/>  </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of findings: Memantine versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/full#CD011335-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011335-tbl-0002"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Summary of findings: Goal Management Training versus Brain Health Program versus wait‐listed control</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Cognitive performance measure</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Goal Management Training</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Brain Health Program</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Wait‐listed control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Goal Management Training</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Brain Health Program</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Wait‐listed control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>N</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Domain composite score change post‐training compared to baseline (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>N</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Domain composite score change post‐training compared to baseline (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>N</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Domain composite score change post‐training compared to baseline (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>N</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Domain composite score change at 4‐month follow‐up compared to baseline (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>N</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Domain composite score change at 4‐month follow‐up compared to baseline (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>N</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Domain composite score change at 4‐month follow‐up compared to baseline (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Executive composite</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.54)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.08 (0.43)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.44 (0.45)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.077</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.69 (0.51)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.13 (0.50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.07 (0.44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.046</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Memory composite</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.40 (0.84)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.11 (0.91)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.43 (0.76)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.778</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.08 (0.82)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.86 (1.01)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.84 (0.52)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.842</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Processing speed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.44 (0.55)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.47 (0.43)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.65 (1.53)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.071</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.54 (0.57)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.14 (0.94)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.18 (1.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.179</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="15"> <div class="table-footnote"> <p>SD: standard deviation</p> <p>P values refer to time‐by‐group interaction (intervention) effects on change compared to baseline, using analysis of variance </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Summary of findings: Goal Management Training versus Brain Health Program versus wait‐listed control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/full#CD011335-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011335-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Prevention: Memantine versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Cognitive functioning composite score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Cognitive functioning sub‐tests <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Short‐term verbal memory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Long‐term verbal memory (recall)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.3 Long‐term verbal memory (recognition)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.4 Trail making test A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.5 Trail making test B</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.6 Verbal fluency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>508</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.76, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Prevention: Memantine versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011335-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Prevention: d‐threo‐methylphenidate versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 General cognitive functioning <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Depression <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Fatigue <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.30 [‐10.37, 16.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Quality of life <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 FACT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.2 Brain subscale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Prevention: d‐threo‐methylphenidate versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011335-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Prevention: Cognitive rehabilitation versus standard care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Cognitive functioning <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Cognitive functioning sub‐test <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 Attention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.2 Short‐term verbal memory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.3 Short‐term visual memory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.4 Long‐term verbal/visual memory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.5 Language</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Mood <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Fatigue <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 Functional capacity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.55 [‐22.57, 5.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.6 Quality of life <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.00 [‐21.55, 33.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Prevention: Cognitive rehabilitation versus standard care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011335-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Amelioration: Methylphenidate versus modafinil</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Cognitive functioning (calculated score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.1 Attention (Digit Span)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.03, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.2 Speed of processing (Digit symbol)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [‐0.30, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Cognitive functioning (timed tasks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.1 Speed of processing (TMTA)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.48 [‐4.82, ‐0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.2 Executive function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [‐0.50, 1.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.3 Psychomotor functioning (dominant hand)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [‐1.36, 2.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.4 Psychomotor functioning (non‐dominant hand)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.38 [‐51.16, 40.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 Cognitive functioning (total score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.1 Verbal fluency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [‐0.16, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.2 Short‐term verbal memory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [‐0.35, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.3 Long‐term verbal memory (recall)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.38 [‐2.00, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.4 Long‐term verbal memory (recognition)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.62 [‐0.56, 3.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.4 Self‐reported confusion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.04 [‐4.76, 2.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.5 Anxiety <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5.1 STAI State anxiety</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.35 [‐11.66, 8.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5.2 STAI Trait anxiety</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.83 [‐22.21, 20.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5.3 POMS anxiety</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.56 [‐0.37, 7.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.6 Depression <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.6.1 BDI‐II</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [‐1.93, 2.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.6.2 POMS depression‐dejection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [‐0.48, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.7 Anger <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.50 [‐5.99, 4.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.8 Fatigue <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.8.1 Brief Fatigue Inventory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.20 [‐12.56, 2.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.8.2 POMS‐Fat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [‐1.30, 1.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.9 Sleep <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.39 [‐6.27, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.10 Activity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.94 [‐1.79, 5.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.11 Quality of life <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.71 [‐14.46, 19.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Amelioration: Methylphenidate versus modafinil</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011335-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Amelioration: Donepezil versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Cognitive composite score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.05, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Cognitive functioning (timed tasks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.1 Speed of processing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.82 [‐11.49, 7.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.2 Executive function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.61 [‐15.98, 19.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.3 Psychomotor functioning (dominant hand)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.93 [‐21.51, ‐2.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.4 Psychomotor functioning (non‐dominant hand)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐5.21, 5.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.3 Cognitive functioning (total score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.1 Attention (Digit span (total))</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.16 [‐1.12, 0.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.2 Attention (Digit span (backward))</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐1.01, 0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.3 Attention (Digit Span (forward))</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.57, 0.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.4 Verbal fluency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.92 [‐3.19, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.5 Short‐term verbal memory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [‐0.93, 1.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.6 Long‐term verbal memory (recall)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [‐0.36, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.7 Long‐term verbal memory (retention)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.96 [‐4.40, 12.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.8 Long‐term verbal memory (recognition)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.07, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.9 Long‐term verbal memory (discrimination)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.27, 1.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.10 Short‐term visual memory (copy)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.69 [‐1.63, 0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.11 Short‐term visual memory (recall)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.50 [‐1.51, 0.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.12 Long‐term visual memory (retention)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.39 [‐1.48, 0.70]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Amelioration: Donepezil versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011335-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Amelioration: Goal management training versus brain health program versus wait‐listed control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Cognitive performance measures: Goal management training versus wait‐list control <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.1 Executive composite ‐ immediately post‐training compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.22, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.2 Executive composite ‐ 4 months compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.17, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.3 Memory composite ‐ immediately post‐training compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.94, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.4 Memory composite ‐ 4 months compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [‐0.54, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.5 Processing speed ‐ immediately post‐training compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [‐0.45, 2.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.6 Processing speed ‐ 4 months compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [‐0.50, 1.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 Cognitive performance measures: Goal management training versus brain health program <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.1 Executive composite ‐ immediately post‐training compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [‐0.23, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.2 Executive composite ‐ 4 months compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.05, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.3 Memory composite ‐ immediately post‐training compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [‐0.61, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.4 Memory composite ‐ 4 months compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [‐0.73, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.5 Processing speed ‐ immediately post‐training compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.51, 0.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.6 Processing speed ‐ 4 months compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [‐0.15, 1.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.3 Cognitive performance measures: Brain health program versus wait‐list control <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3.1 Executive composite ‐ immediately post‐training compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [‐0.04, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3.2 Executive composite ‐ 4 months compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐0.44, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3.3 Memory composite ‐ immediately post‐training compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.32 [‐1.36, 0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3.4 Memory composite ‐ 4 months compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.98, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3.5 Processing speed ‐ immediately post‐training compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [‐0.42, 2.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3.6 Processing speed ‐ 4 months compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐1.35, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.4 Patient‐reported outcome measures: Goal management training versus wait‐list control <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4.1 Cognitive symptoms composite ‐ immediately post‐training compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [‐0.23, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4.2 Cognitive symptoms composite ‐ 4 months compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [‐0.24, 0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4.3 Emotional functioning composite ‐ immediately post‐training compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [‐0.24, 0.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4.4 Emotional functioning composite ‐ 4 months compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.73, 0.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4.5 Coping/adjusting composite ‐ immediately post‐training compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.69, 0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4.6 Coping/adjusting composite ‐ 4 months compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐0.82, 0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.5 Patient‐reported outcome measures: Goal management training versus brain health program <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5.1 Cognitive symptoms composite ‐ immediately post‐training compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.28 [‐0.68, 0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5.2 Cognitive symptoms composite ‐ 4 months compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.64 [‐1.05, ‐0.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5.3 Emotional functioning composite ‐ immediately post‐training compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐0.51, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5.4 Emotional functioning composite ‐ 4 months compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.29 [‐0.69, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5.5 Coping/adjustment composite ‐ immediately post‐training compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.57, 0.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5.6 Coping/adjustment composite ‐ 4 months compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.24 [‐0.60, 0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.6 Patient‐reported outcome measures: Brain health program versus wait‐list control <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.1 Cognitive symptoms composite ‐ immediately post‐training compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.04, 1.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.2 Cognitive symptoms composite ‐ 4 months compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.34, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.3 Emotional functioning composite ‐ immediately post‐training compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [‐0.04, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.4 Emotional functioning composite ‐ 4 months compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [‐0.39, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.5 Coping/adjustment composite ‐ immediately post‐training compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [‐0.61, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.6 Coping/adjustment composite ‐ 4 months compared to baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [‐0.57, 0.67]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Amelioration: Goal management training versus brain health program versus wait‐listed control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011335.pub3/references#CD011335-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011335.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD011335-note-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD011335-note-0014">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011335-note-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011335-note-0013">Français</a> </li> <li class="section-language"> <a class="" href="id#CD011335-note-0011">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="ja#CD011335-note-0010">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD011335-note-0007">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD011335-note-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD011335-note-0008">Português</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD011335-note-0006">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011335\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011335\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011335\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011335\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011335\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011335\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011335\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011335\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011335\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011335\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011335\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011335\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011335\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011335\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011335\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011335\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011335\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011335\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=bzu3XIhG&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011335.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011335.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011335.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011335.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011335.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727633301"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011335.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727633305"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011335.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918eb0d01942936d',t:'MTc0MDcyNzYzMy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 